P38G
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S494 | Sugiyama | SHTN1 KIAA1598 | EtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsVs |
| A0MZ66 | S532 | Sugiyama | SHTN1 KIAA1598 | sVssVTKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTS |
| A0MZ66 | S534 | Sugiyama | SHTN1 KIAA1598 | ssVTKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTSSK |
| A0MZ66 | T537 | Sugiyama | SHTN1 KIAA1598 | TKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTSSKVTF |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NKT7 | T1475 | Sugiyama | RGPD3 RGP3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S130 | Sugiyama | PDLIM1 CLIM1 CLP36 | PQEVLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGL |
| O00161 | S110 | Sugiyama | SNAP23 | TKNFEsGKAYKttWGDGGENsPCNVVSKQPGPVTNGQLQQP |
| O00178 | S12 | Sugiyama | GTPBP1 | _________MATERsRsAMDsPVPAsMFAPEPssPGAARAA |
| O00178 | S25 | Sugiyama | GTPBP1 | RsRsAMDsPVPAsMFAPEPssPGAARAAAAAARLHGGFDsD |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00418 | S396 | SIGNOR|iPTMNet | EEF2K | LsENSGDENMSDVTFDsLPSsPsSATPHSQKLDHLHWPVFS |
| O00499 | S296 | Sugiyama | BIN1 AMPHL | sNTFtVKAQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEP |
| O00499 | S303 | Sugiyama | BIN1 AMPHL | AQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEPAGGAt |
| O00512 | S120 | Sugiyama | BCL9 | ERsIsADsFDQRDPGtPNDDsDIKECNSADHIKSQDSQHtP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S480 | Sugiyama | TRAFD1 FLN29 | ATYNQLSRstsGPRPGCQPssPCVPKLsNsDsQDIQGRNRD |
| O14545 | T323 | Sugiyama | TRAFD1 FLN29 | ELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQ |
| O14715 | T1474 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| O14745 | S186 | Sugiyama | NHERF1 NHERF SLC9A3R1 | FNLHSDKSKPGQFIRsVDPDsPAEAsGLRAQDRIVEVNGVC |
| O14745 | S280 | Sugiyama | NHERF1 NHERF SLC9A3R1 | tNGEIQKENsREALAEAALEsPRPALVRsAssDtsEELNsQ |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14950 | T128 | Sugiyama | MYL12B MRLC2 MYLC2B | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| O14979 | S241 | Sugiyama | HNRNPDL HNRPDL JKTBP | KRAKALKGKEPPKKVFVGGLsPDtsEEQIKEYFGAFGEIEN |
| O15014 | S804 | Sugiyama | ZNF609 KIAA0295 | RLASIKAEADKIySFtDNAPsPsIGGssRLENttPtQPLtP |
| O15061 | S1181 | Sugiyama | SYNM DMN KIAA0353 SYN | AAsPtGASRSVRHVTLGPGQsPLsREVIFLGPAPACPEAWG |
| O43242 | T69 | Sugiyama | PSMD3 | GEADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGK |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43464 | S142 | PSP | HTRA2 OMI PRSS25 | WGGGRGPPAVLAAVPSPPPAsPRSQyNFIADVVEKTAPAVV |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60239 | S351 | SIGNOR|iPTMNet | SH3BP5 SAB | PSEMPDQFPAVVRPGSLDLPsPVsLsEFGMMFPVLGPRsEC |
| O60239 | S421 | SIGNOR|iPTMNet | SH3BP5 SAB | NRGLSSSSGSGGSSKsQsstsPEGQALENRMKQLSLQCSKG |
| O60333 | T647 | Sugiyama | KIF1B KIAA0591 KIAA1448 | GKNHVFRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELL |
| O60333 | T652 | Sugiyama | KIF1B KIAA0591 KIAA1448 | FRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEKQGI |
| O60353 | S620 | Sugiyama | FZD6 | VKADGAstPRLREQDCGEPAsPAAsIsRLsGEQVDGKGQAG |
| O60664 | S91 | Sugiyama | PLIN3 M6PRBP1 TIP47 | TAAAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQ |
| O60701 | T185 | Sugiyama | UGDH | EGTAIKDLKNPDRVLIGGDEtPEGQRAVQALCAVYEHWVPR |
| O75179 | S2042 | Sugiyama | ANKRD17 GTAR KIAA0697 | TAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLD |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75369 | S2274 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | AQEPGNYEVSIKFNDEHIPEsPyLVPVIAPSDDARRLTVMS |
| O75391 | S158 | Sugiyama | SPAG7 | LKELAQRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKD |
| O75533 | T203 | Sugiyama | SF3B1 SAP155 | VVNGAAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEt |
| O75533 | T207 | Sugiyama | SF3B1 SAP155 | AAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHt |
| O75533 | T211 | Sugiyama | SF3B1 SAP155 | QPPsKRKRRWDQtADQtPGAtPKKLssWDQAEtPGHtPsLR |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75822 | T109 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKRQEEIKKRLEEPEEPKVLtPEEQLADKLRLKKLQEEsDL |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O95297 | S210 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | LYRRKNSKRDyTGCstsEsLsPVKQAPRKsPsDtEGLVKSL |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95359 | T2314 | Sugiyama | TACC2 | VAKMPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGT |
| O95359 | T2514 | Sugiyama | TACC2 | DYPQPSDLSTFVNETKFssPtEELDyRNsYEIEyMEKIGss |
| O95365 | S549 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | ARRNGQEKHFKDEDEDEDVAsPDGLGRLNVAGAGGGGDsGG |
| O95425 | S920 | Sugiyama | SVIL | LDHNAsAtDYKFSssIENsDsPVRSILKSQAWQPLVEGsEN |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00367 | T410 | Sugiyama | GLUD1 GLUD | KSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLYL |
| P00519 | T844 | Sugiyama | ABL1 ABL JTK7 | VAPAsGLPHKEEAGKGSALGtPAAAEPVtPTsKAGSGAPGG |
| P00519 | T852 | Sugiyama | ABL1 ABL JTK7 | HKEEAGKGSALGtPAAAEPVtPTsKAGSGAPGGTSKGPAEE |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04083 | S34 | Sugiyama | ANXA1 ANX1 LPC1 | IENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKA |
| P04083 | S37 | Sugiyama | ANXA1 ANX1 LPC1 | EEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMV |
| P04083 | Y39 | Sugiyama | ANXA1 ANX1 LPC1 | QEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMVKG |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T103 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsA |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04637 | S33 | PSP | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04843 | S385 | Sugiyama | RPN1 | IDSLTVKIILPEGAKNIEIDsPyEISRAPDELHYTYLDTFG |
| P04920 | S172 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | VQFFLQEDDSADRKAERtsPssPAPLPHQEAtPRASKGAQA |
| P05114 | S86 | Sugiyama | HMGN1 HMG14 | ANQETKEDLPAENGEtKtEEsPAsDEAGEKEAKsD______ |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05187 | S438 | Sugiyama | ALPP PLAP | GPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETHAGED |
| P05387 | S17 | Sugiyama | RPLP2 D11S2243E RPP2 | ____MRyVAsyLLAALGGNssPsAKDIKKILDsVGIEADDD |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S74 | SIGNOR | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07814 | S1350 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | YRRRLLsVNIRVRADLRDNysPGWKFNHWELKGVPIRLEVG |
| P07814 | S688 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | DIIQLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtK |
| P07814 | S886 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLFD |
| P07814 | T898 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLsQssDssPtRNsEPAGLEtPEAKVLFDKVAsQGEVVRKL |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S595 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | MKDILEKKVEKVVVSNRLVtsPCCIVtstyGWTANMERIMK |
| P07942 | S658 | Sugiyama | LAMB1 | PTSSRCGNTIPDDDNQVVsLsPGSRYVVLPRPVCFEKGTNY |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08651 | S323 | Sugiyama | NFIC NFI | PssPtsSSRNWTEDMEGGIssPVKKtEMDKsPFNsPsPQDs |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09234 | S17 | Sugiyama | SNRPC | ____MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENVKDY |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DJD0 | T1459 | Sugiyama | RGPD1 RANBP2L6 RGP1 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P10398 | S186 | Sugiyama | ARAF ARAF1 PKS PKS2 | RQHEAPsNRPLNELLtPQGPsPRTQHCDPEHFPFPAPANAP |
| P10398 | T181 | Sugiyama | ARAF ARAF1 PKS PKS2 | LsGGsRQHEAPsNRPLNELLtPQGPsPRTQHCDPEHFPFPA |
| P10636 | S519 | SIGNOR | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S637 | SIGNOR | MAPT MAPTL MTBT1 TAU | VPGGGsVQIVyKPVDLSKVTsKCGsLGNIHHKPGGGQVEVK |
| P10636 | T123 | iPTMNet | MAPT MAPTL MTBT1 TAU | AEEAGIGDtPSLEDEAAGHVtQEPESGKVVQEGFLREPGPP |
| P10636 | T173 | iPTMNet | MAPT MAPTL MTBT1 TAU | MPGAPLLPEGPREATRQPsGtGPEDTEGGRHAPELLKHQLL |
| P10636 | T498 | SIGNOR | MAPT MAPTL MTBT1 TAU | GQKGQANATRIPAKtPPAPKtPPsSGEPPKsGDRsGyssPG |
| P10636 | T522 | SIGNOR | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10636 | T548 | SIGNOR | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10696 | S435 | Sugiyama | ALPG ALPPL ALPPL2 | GPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETHAGED |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11532 | S3613 | Sugiyama | DMD | LRQLLEQPQAEAKVNGttVssPstsLQRsDssQPMLLRVVG |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P13051 | S64 | Sugiyama | UNG DGU UNG1 UNG15 | AAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAAALLR |
| P13051 | T60 | Sugiyama | UNG DGU UNG1 UNG15 | SGDAAAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAA |
| P13639 | S502 | Sugiyama | EEF2 EF2 | tGtIttFEHAHNMRVMKFsVsPVVRVAVEAKNPADLPKLVE |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13798 | S304 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLIP |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13807 | S723 | PSP|Sugiyama | GYS1 GYS | TSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN______ |
| P13807 | S727 | PSP|Sugiyama | GYS1 GYS | KRNsVDtAtsssLstPsEPLsPtssLGEERN__________ |
| P13807 | T278 | PSP | GYS1 GYS | VSQITAIEAQHLLKRKPDIVtPNGLNVKKFsAMHEFQNLHA |
| P13807 | T721 | Sugiyama | GYS1 GYS | sSTSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN____ |
| P14314 | S442 | Sugiyama | PRKCSH G19P1 | EYVYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSA |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14854 | S52 | Sugiyama | COX6B1 COX6B | QNyLDFHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTD |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15172 | S200 | SIGNOR|PSP | MYOD1 BHLHC1 MYF3 MYOD | APGPLPPGRGGEHYSGDSDAssPRSNCSDGMMDYSGPPSGA |
| P15172 | S201 | SIGNOR|PSP | MYOD1 BHLHC1 MYF3 MYOD | PGPLPPGRGGEHYSGDSDAssPRSNCSDGMMDYSGPPSGAR |
| P15336 | T69 | Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | PSP|Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P16949 | S25 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17066 | T40 | Sugiyama | HSPA6 HSP70B' | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P17174 | S93 | Sugiyama | GOT1 | PILGLAEFRsCAsRLALGDDsPALKEKRVGGVQsLGGtGAL |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18827 | S233 | Sugiyama | SDC1 SDC | FETSGENTAVVAVEPDRRNQsPVDQGAtGAsQGLLDRKEVL |
| P18858 | S51 | Sugiyama | LIG1 | TEPPPKAALKEWNGVVsEsDsPVKRPGRKAARVLGsEGEEE |
| P18858 | S76 | Sugiyama | LIG1 | PGRKAARVLGsEGEEEDEALsPAKGQKPALDCsQVsPPRPA |
| P19105 | T127 | Sugiyama | MYL12A MLCB MRLC3 RLC | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P22681 | S900 | Sugiyama | CBL CBL2 RNF55 | IAQNNIEMAKNILREFVSIssPAHVAT______________ |
| P23246 | T687 | Sugiyama | SFPQ PSF | FGQGGAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P23921 | S562 | Sugiyama | RRM1 RR1 | ASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLWDWK |
| P24534 | S8 | Sugiyama | EEF1B2 EEF1B EF1B | _____________MGFGDLKsPAGLQVLNDyLADKSYIEGY |
| P24844 | T128 | Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | ACFDEEASGFIHEDHLRELLttMGDRFtDEEVDEMyREAPI |
| P25054 | S1100 | Sugiyama | APC DP2.5 | ESTDDKHLKFQPHFGQQECVsPYRSRGANGSETNRVGSNHG |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P25789 | S13 | Sugiyama | PSMA4 HC9 PSC9 | ________MSRRyDsRttIFsPEGRLYQVEYAMEAIGHAGT |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26038 | T465 | Sugiyama | MSN | WQQKAQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDE |
| P26038 | T469 | Sugiyama | MSN | AQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDENGAE |
| P26045 | S459 | PSP | PTPN3 PTPH1 | sLsENNPAQSYLTQKssssVsPSSNAPGsCsPDGVDQQLLD |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S280 | Sugiyama | MAP4 | LAKDMALATKTEVALAKDMEsPtKLDVtLAKDMQPSMESDM |
| P27816 | T282 | Sugiyama | MAP4 | KDMALATKTEVALAKDMEsPtKLDVtLAKDMQPSMESDMAL |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28715 | S384 | Sugiyama | ERCC5 ERCM2 XPG XPGC | ENRRQARGRNAPAAVDEGsIsPRtLSAIKRALDDDEDVKVC |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29966 | S101 | Sugiyama | MARCKS MACS PRKCSL | sPsAAEKGEPAAAAAPEAGAsPVEKEAPAEGEAAEPGsPtA |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P30101 | Y269 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | EDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMMVAKK |
| P30281 | T283 | PSP | CCND3 | ssPAPKAPRGsssQGPsQtstPtDVtAIHL___________ |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S248 | Sugiyama | SFN HME1 | tLWTADNAGEEGGEAPQEPQs____________________ |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32004 | S1248 | Sugiyama | L1CAM CAML1 MIC5 | QySGKKEKEAAGGNDssGAtsPINPAVALE___________ |
| P33176 | S175 | Sugiyama | KIF5B KNS KNS1 | VHEDKNRVPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVT |
| P33316 | S99 | Sugiyama | DUT | KGELPKAGGsPAPGPEtPAIsPsKRARPAEVGGMQLRFARL |
| P33316 | T95 | Sugiyama | DUT | AAGWKGELPKAGGsPAPGPEtPAIsPsKRARPAEVGGMQLR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35222 | S605 | PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | HNRIVIRGLNTIPLFVQLLYsPIENIQRVAAGVLCELAQDK |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35638 | S79 | ELM | DDIT3 CHOP CHOP10 GADD153 | SLAWLTEEEPEPAEVTSTSQsPHsPDSSQSSLAQEEEEEDQ |
| P35638 | S82 | ELM | DDIT3 CHOP CHOP10 GADD153 | WLTEEEPEPAEVTSTSQsPHsPDSSQSSLAQEEEEEDQGRT |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36956 | S63 | PSP | SREBF1 BHLHD1 SREBP1 | FPGLFDPPYAGSGAGGtDPAsPDTSSPGSLSPPPATLSSSL |
| P36956 | T426 | PSP | SREBF1 BHLHD1 SREBP1 | SGGNTDVLMEGVKTEVEDTLtPPPsDAGsPFQSsPLSLGSR |
| P37198 | S272 | SIGNOR|PSP | NUP62 | GTQGFSLKAPGAASGTStTTsTAATATATTTSSSSTTGFAL |
| P37198 | T269 | SIGNOR|PSP | NUP62 | PTAGTQGFSLKAPGAASGTStTTsTAATATATTTSSSSTTG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40222 | S514 | Sugiyama | TXLNA TXLN | GsLtDsGPERRPEGPGAQAPssPRVtEAPCyPGAPSTEASG |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P43121 | T107 | Sugiyama | MCAM MUC18 | EYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQEYR |
| P46013 | S2105 | Sugiyama | MKI67 | tPDHTEESttDDKTTKIACKsPPPEsMDtPTstRRRPKtPL |
| P46013 | S308 | Sugiyama | MKI67 | VSRKSRPKsGGsGHAVAEPAsPEQELDQNKGKGRDVEsVQt |
| P46013 | T2113 | Sugiyama | MKI67 | ttDDKTTKIACKsPPPEsMDtPTstRRRPKtPLGKRDIVEE |
| P46087 | S732 | Sugiyama | NOP2 NOL1 NSUN1 | AFLRQNAPPKGTDtQtPAVLsPsKtQAtLKPKDHHQPLGRA |
| P46087 | T727 | Sugiyama | NOP2 NOL1 NSUN1 | SSKKVAFLRQNAPPKGTDtQtPAVLsPsKtQAtLKPKDHHQ |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S289 | Sugiyama | YAP1 YAP65 | MNQRIsQsAPVKQPPPLAPQsPQGGVMGGsNsNQQQQMRLQ |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P48741 | T40 | Sugiyama | HSPA7 HSP70B | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P49023 | S106 | Sugiyama | PXN | PVyGssAKtssVsNPQDsVGsPCsRVGEEEHVysFPNKQKs |
| P49023 | S84 | Sugiyama | PXN | DPLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsV |
| P49023 | S85 | Sugiyama | PXN | PLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVG |
| P49321 | T390 | Sugiyama | NASP | EAPVLPKDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGL |
| P49448 | T410 | Sugiyama | GLUD2 GLUDP1 | KSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLYL |
| P49753 | S360 | Sugiyama | ACOT2 PTE2 PTE2A | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| P49757 | S634 | Sugiyama | NUMB C14orf41 | DPFEAQWAALENKSKQRtNPsPtNPFSSDLQKTFEIEL___ |
| P49792 | S2628 | Sugiyama | RANBP2 NUP358 | NytFKtPEKAKEKKKPEDsPsDDDVLIVyELtPTAEQKALA |
| P49792 | T1761 | Sugiyama | RANBP2 NUP358 | ATKCIACQCPSKQNQtTAIstPAssEIsKAPKsGFEGMFIR |
| P49792 | T2450 | Sugiyama | RANBP2 NUP358 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| P49792 | T2639 | Sugiyama | RANBP2 NUP358 | EKKKPEDsPsDDDVLIVyELtPTAEQKALATKLKLPPTFFC |
| P49815 | S1449 | Sugiyama | TSC2 TSC4 | AWSASGEDSRGQPEGPLPsssPRsPsGLRPRGYtIsDsAPs |
| P49815 | S1452 | Sugiyama | TSC2 TSC4 | ASGEDSRGQPEGPLPsssPRsPsGLRPRGYtIsDsAPsRRG |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50552 | S337 | Sugiyama | VASP | LPRMKssssVttsEtQPCtPsSSDySDLQRVKQELLEEVKK |
| P50552 | T335 | Sugiyama | VASP | tTLPRMKssssVttsEtQPCtPsSSDySDLQRVKQELLEEV |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P51991 | Y360 | Sugiyama | HNRNPA3 HNRPA3 | QSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF__ |
| P52564 | S275 | Sugiyama | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | FPYDSWGTPFQQLKQVVEEPsPQLPADKFSAEFVDFTSQCL |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52597 | S285 | Sugiyama | HNRNPF HNRPF | syCLsGMyDHRYGDsEFtVQsTTGHCVHMRGLPYKAtENDI |
| P52630 | Y690 | PSP | STAT2 | RDEAFGCYYQEKVNLQERRKyLKHRLIVVSNRQVDELQQPL |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53778 | S180 | Sugiyama | MAPK12 ERK6 SAPK3 | AVNEDCELKILDFGLARQADsEMtGyVVtRWYRAPEVILNW |
| P53778 | S3 | ELM|iPTMNet|EPSD|PSP | MAPK12 ERK6 SAPK3 | __________________MSsPPPARSGFYRQEVTKTAWEV |
| P53778 | S35 | Sugiyama | MAPK12 ERK6 SAPK3 | EVTKTAWEVRAVYRDLQPVGsGAyGAVCsAVDGRtGAKVAI |
| P53778 | S43 | Sugiyama | MAPK12 ERK6 SAPK3 | VRAVYRDLQPVGsGAyGAVCsAVDGRtGAKVAIKKLYRPFQ |
| P53778 | T183 | Sugiyama | MAPK12 ERK6 SAPK3 | EDCELKILDFGLARQADsEMtGyVVtRWYRAPEVILNWMRY |
| P53778 | T49 | Sugiyama | MAPK12 ERK6 SAPK3 | DLQPVGsGAyGAVCsAVDGRtGAKVAIKKLYRPFQSELFAK |
| P53778 | Y185 | Sugiyama | MAPK12 ERK6 SAPK3 | CELKILDFGLARQADsEMtGyVVtRWYRAPEVILNWMRYTQ |
| P53778 | Y38 | Sugiyama | MAPK12 ERK6 SAPK3 | KTAWEVRAVYRDLQPVGsGAyGAVCsAVDGRtGAKVAIKKL |
| P53992 | S328 | Sugiyama | SEC24C KIAA0079 | sQPGPPQPLPPKRLDPDAIPsPIQVIEDDRNNRGTEPFVTG |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | T223 | Sugiyama | CLNS1A CLCI ICLN | AGVRtEDsIRDyEDGMEVDttPtVAGQFEDADVDH______ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55786 | S684 | Sugiyama | NPEPPS PSA | TLLSHTDFYEEIQEFVKDVFsPIGERLGWDPKPGEGHLDAL |
| P55789 | S59 | Sugiyama | GFER ALR HERV1 HPO | AGRRDAAASASTPAQAPTsDsPVAEDASRRRPCRACVDFKT |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P56945 | S18 | Sugiyama | BCAR1 CAS CASS1 CRKAS | ___MNHLNVLAKALyDNVAEsPDELSFRKGDIMTVLEQDTQ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60866 | T6 | Sugiyama | RPS20 | _______________MAFKDtGKtPVEPEVAIHRIRITLTS |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S82 | Sugiyama | HNRNPK HNRPK | GKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEILK |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62851 | T69 | Sugiyama | RPS25 | LFDKAtyDKLCKEVPNYKLItPAVVsERLKIRGSLARAALQ |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78316 | S96 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | ERDKSNVFRDKRFGEyNsNMsPEEKMMKRFALEQQRHHEKK |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P80723 | T36 | Sugiyama | BASP1 NAP22 | DEKAKEKDKKAEGAAtEEEGtPKEsEPQAAAEPAEAKEGKE |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P85037 | S445 | Sugiyama | FOXK1 MNF | GLMsPRsGGLQtPECLsREGsPIPHDPEFGsKLASVPEYRY |
| Q00613 | S303 | PSP | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00613 | S307 | PSP | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q00613 | S326 | PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | T357 | Sugiyama | HSF1 HSTF1 | EsEPAPAsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVA |
| Q00613 | T367 | Sugiyama | HSF1 HSTF1 | ALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDH |
| Q00613 | T369 | Sugiyama | HSF1 HSTF1 | tDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLD |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q02952 | S283 | Sugiyama | AKAP12 AKAP250 | EECKEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQG |
| Q02952 | S286 | Sugiyama | AKAP12 AKAP250 | KEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWAG |
| Q02952 | S483 | Sugiyama | AKAP12 AKAP250 | LVKLKEtCVsGEDPTQGADLsPDEKVLSKPPEGVVSEVEML |
| Q02952 | T285 | Sugiyama | AKAP12 AKAP250 | CKEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWA |
| Q04726 | T259 | Sugiyama | TLE3 KIAA1547 | DsDGDKsDDLVVDVsNEDPAtPRVsPAHsPPENGLDKARSL |
| Q04917 | S38 | Sugiyama | YWHAH YWHA1 | ERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKNVVGARRS |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05682 | S724 | Sugiyama | CALD1 CAD CDM | VPAEGVRNIKsMWEKGNVFssPtAAGtPNKEtAGLKVGVSs |
| Q05682 | T730 | Sugiyama | CALD1 CAD CDM | RNIKsMWEKGNVFssPtAAGtPNKEtAGLKVGVSsRINEWL |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | T163 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | FDGEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALV |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | S1617 | Sugiyama | TJP1 ZO1 | AEKPKyQINNISTVPKAIPVsPsAVEEDEDEDGHTVVATAR |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S1319 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAstts |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09666 | S216 | Sugiyama | AHNAK PM227 | DVEtQsGKtVIRLPsGsGAAsPtGsAVDIRAGAIsAsGPEL |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q09666 | T4564 | Sugiyama | AHNAK PM227 | LEGDLKGPKVDVKGPKVGIDtPDIDIHGPEGKLKGPKFKMP |
| Q12774 | S445 | Sugiyama | ARHGEF5 TIM | ASYLMTQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISL |
| Q12774 | S450 | Sugiyama | ARHGEF5 TIM | TQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISLLGsFL |
| Q12888 | T1609 | SIGNOR | TP53BP1 | SLEQGNRLREQYGLGPYEAVtPLtKAADIsLDNLVEGKRKR |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q12959 | S158 | PSP | DLG1 | sEKNLsEIENVHGFVSHSHIsPIKPTEAVLPSPPTVPVIPV |
| Q12959 | S443 | PSP | DLG1 | SSQPVDNHVsPSSFLGQtPAsPARYSPVSKAVLGDDEITRE |
| Q12959 | T209 | PSP | DLG1 | LPTIPQANPPPVLVNTDSLEtPTYVNGTDADYEYEEITLER |
| Q13066 | T39 | Sugiyama | GAGE2B GAGE2; GAGE2C | PPEMIGPMRPEQFsDEVEPAtPEEGEPATQRQDPAAAQEGE |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13263 | S752 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DQPGGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQF |
| Q13263 | S757 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKLTE |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13409 | T95 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | IVFSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsRTLH |
| Q13424 | S193 | SIGNOR|ELM|iPTMNet|EPSD | SNTA1 SNT1 | SPYFKNStGGtsVGWDsPPAsPLQRQPssPGPTPRNFSEAK |
| Q13424 | S201 | SIGNOR|ELM|iPTMNet|EPSD | SNTA1 SNT1 | GGtsVGWDsPPAsPLQRQPssPGPTPRNFSEAKHMSLKMAY |
| Q13428 | S678 | Sugiyama | TCOF1 | PVRVGTQAPRKAGtAtsPAGssPAVAGGtQRPAEDssssEE |
| Q13428 | S679 | Sugiyama | TCOF1 | VRVGTQAPRKAGtAtsPAGssPAVAGGtQRPAEDssssEEs |
| Q13428 | S777 | Sugiyama | TCOF1 | EKQEDsEssEEEsDSEEAAAsPAQVKTSVKKTQAKANPAAA |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13451 | S13 | Sugiyama | FKBP5 AIG6 FKBP51 | ________MttDEGAKNNEEsPtAtVAEQGEDITsKKDRGV |
| Q13451 | T46 | Sugiyama | FKBP5 AIG6 FKBP51 | TsKKDRGVLKIVKRVGNGEEtPMIGDKVyVHYKGKLSNGKK |
| Q13501 | S272 | PSP | SQSTM1 ORCA OSIL | GIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssCCsD |
| Q13501 | T269 | PSP | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13541 | S65 | Sugiyama | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13610 | S57 | Sugiyama | PWP1 | AEAKEKLQEEGGGsDEEEtGsPsEDGMQsARTQARPREPLE |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14135 | S149 | Sugiyama | VGLL4 KIAA0121 | LEQPLALTKNsLDAsRPAGLsPtLtPGERQQNRPSVITCAS |
| Q14135 | T153 | Sugiyama | VGLL4 KIAA0121 | LALTKNsLDAsRPAGLsPtLtPGERQQNRPSVITCASAGAR |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S477 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLTSK |
| Q14157 | T419 | Sugiyama | UBAP2L KIAA0144 NICE4 | PsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQEKs |
| Q14160 | S1486 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RHQERLRVQsPEPPAPERALsPAELRALEAEKRALWRAARM |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14204 | S3082 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | LHVVFTMNPSSEGLKDRAAtsPALFNRCVLNWFGDWSTEAL |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14676 | S793 | Sugiyama | MDC1 KIAA0170 NFBD1 | EAyGPCLsPPRAIPGDQHPEsPVHtEPMGIQGRGRQTVDKV |
| Q14676 | T797 | Sugiyama | MDC1 KIAA0170 NFBD1 | PCLsPPRAIPGDQHPEsPVHtEPMGIQGRGRQTVDKVMGIP |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15003 | S81 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | EKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsATIPK |
| Q15084 | S248 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | LAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRsDIVsRALDL |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15365 | S190 | Sugiyama | PCBP1 | LsQsPQGRVMtIPyQPMPAssPVICAGGQDRCsDAAGYPHA |
| Q15545 | S201 | Sugiyama | TAF7 TAF2F TAFII55 | WEIIAEDETKEAENQGLDIssPGMsGHRQGHDsLEHDELRE |
| Q15642 | S304 | Sugiyama | TRIP10 CIP4 STOT STP | FEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWPFG |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15942 | S267 | Sugiyama | ZYX | LANtQPRGPPAssPAPAPKFsPVtPKFtPVAsKFsPGAPGG |
| Q15942 | T270 | Sugiyama | ZYX | tQPRGPPAssPAPAPKFsPVtPKFtPVAsKFsPGAPGGsGs |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16643 | T346 | Sugiyama | DBN1 D0S117E | RRMAPtPIPtRsPsDsstAstPVAEQIERALDEVTsSQPPP |
| Q16658 | S127 | Sugiyama | FSCN1 FAN1 HSN SNL | AHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHPQVNIYSV |
| Q32MZ4 | S733 | Sugiyama | LRRFIP1 GCF2 TRIP | ssPAEPKsEDADRCtLPEHEsPsQDIsDACEAEsTERCEMS |
| Q32MZ4 | S735 | Sugiyama | LRRFIP1 GCF2 TRIP | PAEPKsEDADRCtLPEHEsPsQDIsDACEAEsTERCEMSEH |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5JSH3 | S50 | Sugiyama | WDR44 RPH11 | KVGLSTFKETENTAYKVGNEsPVQELKQDVSKKIIEsIIEE |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5UIP0 | S2161 | Sugiyama | RIF1 | NNAsPQKLRELDPsLVsANDsPsGMQtRCVWsPLAsPStsI |
| Q5UIP0 | S2172 | Sugiyama | RIF1 | DPsLVsANDsPsGMQtRCVWsPLAsPStsILKRGLKRsQED |
| Q5UIP0 | S2176 | Sugiyama | RIF1 | VsANDsPsGMQtRCVWsPLAsPStsILKRGLKRsQEDEIss |
| Q5VT52 | S965 | Sugiyama | RPRD2 KIAA0460 HSPC099 | NsLsQsttGHLSLPQKQyPDsPHPVPHRsLFsPQNtLAAPT |
| Q66K74 | S759 | Sugiyama | MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 | LVsPCEFEHRKAVPMAPAPAsPGssNDssARsQERAGGLGA |
| Q69YN4 | S1579 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCSDFDLHSELERsFLsEPssPGRtKTTKGFKLGKHKHETF |
| Q6JBY9 | S108 | SIGNOR | RCSD1 CAPZIP | KLQANLTFDPAALLPGAsPKsPGLKAMVsPFHsPPstPssP |
| Q6NT46 | T39 | Sugiyama | GAGE2A GAGE2 | PPEMIGPMRPEQFsDEVEPAtPEEGEPATQRQDPAAAQEGQ |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6P1N0 | S208 | Sugiyama | CC2D1A AKI1 LGD2 | EADIPPPVAIGKGPAstPtysPAPTQPAPRIASAPEPRVTL |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | S500 | Sugiyama | FIP1L1 FIP1 RHE | ERTRERERERDHsPtPsVFNsDEERyRYREYAERGYERHRA |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q6VN20 | S365 | Sugiyama | RANBP10 KIAA1464 | DSEVRSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGAD |
| Q6VN20 | S369 | Sugiyama | RANBP10 KIAA1464 | RSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsPsC |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71RC2 | S594 | Sugiyama | LARP4 PP13296 | GLNQttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEP |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z3J3 | T1475 | Sugiyama | RGPD4 RGP4 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z589 | S1136 | Sugiyama | EMSY C11orf30 GL002 | VTKITGGSSVPKLtsPVTsIsPIQASEKTAVSDILKMSLME |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5K2 | S226 | Sugiyama | WAPL FOE KIAA0261 WAPAL | ETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDI |
| Q7Z6Z7 | T2889 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | EAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGsGE |
| Q86TX2 | S298 | Sugiyama | ACOT1 CTE1 | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| Q86UE4 | S146 | Sugiyama | MTDH AEG1 LYRIC | PKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSKKNK |
| Q86UE4 | T143 | Sugiyama | MTDH AEG1 LYRIC | SEKPKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSK |
| Q86W92 | S999 | Sugiyama | PPFIBP1 KIAA1230 | INNLTHMLKEDDMFKDFAARsPsAsItDEDsNV________ |
| Q86X55 | S595 | SIGNOR | CARM1 PRMT4 | SAHYAVNSQFTMGGPAISMAsPMSIPTNTMHYGS_______ |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N1F7 | S430 | Sugiyama | NUP93 KIAA0095 | TEDYLWLKLNQVCFDDDGTssPQDRLTLsQFQKQLLEDYGE |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T3 | S345 | Sugiyama | ARFGAP1 ARF1GAP | DQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWE |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8NE71 | S22 | Sugiyama | ABCF1 ABC50 | PKAPKQQPPEPEWIGDGEstsPsDKVVKKGKKDKKIKKTFF |
| Q8NEY1 | S1000 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PsPPALPMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEA |
| Q8NEY1 | T1006 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEAAFELYS |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TB72 | S82 | Sugiyama | PUM2 KIAA0235 PUMH2 | MVQRRsGQGFHGNsEVNAILsPRsEsGGLGVsMVEYVLsss |
| Q8TBB5 | S424 | Sugiyama | KLHDC4 | APGsAGQPRsEDEDsLEEAGsPAPGPCPRSNAMLAVKHGVL |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TDM6 | S1146 | Sugiyama | DLG5 KIAA0583 PDLG | VVIPAQFLEEQKCVPASGELsPELQEWAPYsPGHSSRHsNP |
| Q8TDM6 | S1156 | Sugiyama | DLG5 KIAA0583 PDLG | QKCVPASGELsPELQEWAPYsPGHSSRHsNPPLYPSRPSVG |
| Q8WUI4 | S109 | Sugiyama | HDAC7 HDAC7A | LAEVILKKQQAALERtVHPNsPGIPYRTLEPLETEGATRSM |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WWM7 | S559 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | RFQLEELRKFGAQFKLQPsssPENsLDPFPPRILKEEPKGK |
| Q8WWM7 | S594 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | EEPKGKEKEVDGLLtsEPMGsPVssKtEsVsDKEDKPPLAP |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92576 | S1614 | Sugiyama | PHF3 KIAA0244 | KRQLQEDQENNLQDNQtsNssPCRsNVGKGNIDGNVsCsEN |
| Q92609 | S539 | Sugiyama | TBC1D5 KIAA0210 | KsEsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssA |
| Q92615 | S664 | Sugiyama | LARP4B KIAA0217 LARP5 | ELRKPSYAEICQRTSKEPPssPLQPQKEQKPNTVGCGKEEK |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q92993 | T158 | PSP | KAT5 HTATIP TIP60 | SCLQPNHRSTKRKVEVVsPAtPVPSETAPASVFPQNGAARR |
| Q96AE4 | S630 | Sugiyama | FUBP1 | DYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ______ |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96CT7 | S207 | Sugiyama | CCDC124 | ENPNMRLsQLKQLLKKEWLRsPDNPMNQRAVPFNAPK____ |
| Q96CW6 | S302 | Sugiyama | SLC7A6OS | SRQRMWSKYPLDVQKEFGyDsPHDLDsD_____________ |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96EK9 | T189 | Sugiyama | KTI12 SBBI81 | DVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFysPELL |
| Q96K76 | S910 | Sugiyama | USP47 | DGDNGDssKstEtsDFENIEsPLNERDsSAsVDNRELEQHI |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96S55 | T87 | Sugiyama | WRNIP1 WHIP | PGAKRRRLsEssALKQPAtPtAAEssEGEGEEGDDGGETES |
| Q96SB4 | S311 | Sugiyama | SRPK1 | EMEKESGPGQKRPNKQEEsEsPVERPLKENPPNKMtQEKLE |
| Q96ST3 | S10 | Sugiyama | SIN3A | ___________MKRRLDDQEsPVyAAQQRRIPGstEAFPHQ |
| Q99081 | S79 | Sugiyama | TCF12 BHLHB20 HEB HTF4 | SWGtsGQPsPsyDssRGFtDsPHYsDHLNDsRLGAHEGLsP |
| Q99666 | T1474 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | DSFKKIFDEAKTAQEKDsLItPHVsRsstPREsPCGKIAVA |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BX68 | T47 | Sugiyama | HINT2 | QVRGAAGVTDGNEVAKAQQAtPGGAAPtIFsRILDKsLPAD |
| Q9BXK5 | S426 | Sugiyama | BCL2L13 MIL1 CD003 | ETLLsEKEINAREEsLVEELsPAsEKKPVPPSEGKsRLsPA |
| Q9BXP5 | S703 | Sugiyama | SRRT ARS2 ASR2 | EEAQKMGRKDPEQEVEKFVtsNtQELGKDKWLCPLsGKKFK |
| Q9BY44 | T512 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | EAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPE |
| Q9BY44 | T518 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | KQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIK |
| Q9BYG3 | T234 | Sugiyama | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZF1 | S65 | Sugiyama | OSBPL8 KIAA1451 ORP8 OSBP10 | QRQGKEAYPtPtKDLHQPsLsPAsPHsQGFERGKEDISQNK |
| Q9BZF1 | S68 | Sugiyama | OSBPL8 KIAA1451 ORP8 OSBP10 | GKEAYPtPtKDLHQPsLsPAsPHsQGFERGKEDISQNKDES |
| Q9C000 | S107 | PSP | NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1 | QEGAGHSPSFPYSPSEPHLGsPSQPTSTAVLMPWIHELPAG |
| Q9C037 | Y449 | Sugiyama | TRIM4 RNF87 | LIGFPGTPTQQEPALHRVGVyLDRGTGNVSFYSAVDGVHLH |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S712 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PPPsGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEF |
| Q9C0C2 | S717 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEFGITGD |
| Q9GZR7 | S166 | Sugiyama | DDX24 | NLVQTAPKKKKNKGKKGLEPsQSTAAKVPKKAKTWIPEVHD |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H1E3 | S214 | Sugiyama | NUCKS1 NUCKS JC7 | AsKAsKEKtPsPKEEDEEPEsPPEKKtstsPPPEKsGDEGs |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S102 | Sugiyama | CCDC86 CYCLON | QGQPEPGAAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSE |
| Q9H6F5 | S113 | Sugiyama | CCDC86 CYCLON | QRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQDQGV |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H8Y8 | S436 | Sugiyama | GORASP2 GOLPH6 | PPtAKAPttVEDRVGDstPVsEKPVsAAVDANAsEsP____ |
| Q9H8Y8 | S451 | Sugiyama | GORASP2 GOLPH6 | DstPVsEKPVsAAVDANAsEsP___________________ |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9HC38 | S246 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | LPDLEDLMKRENQKILtPLVsLDtPGKATVQVVILADPDGH |
| Q9HC38 | T242 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | PQKELPDLEDLMKRENQKILtPLVsLDtPGKATVQVVILAD |
| Q9HCD6 | S169 | Sugiyama | TANC2 KIAA1148 KIAA1636 | tLPPISTNATAKDCSyGAVtsPtstLESRDSGIIATLTSYS |
| Q9HDC9 | T190 | Sugiyama | APMAP C20orf3 UNQ1869/PRO4305 | KGLFEVNPWKREVKLLLSsEtPIEGKNMSFVNDLTVTQDGR |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQW6 | S323 | Sugiyama | ANLN | ITDAKsCEGQNPELLPKtPIsPLKtGVSKPIVKsTLsQtVP |
| Q9NQW6 | T320 | Sugiyama | ANLN | TTSITDAKsCEGQNPELLPKtPIsPLKtGVSKPIVKsTLsQ |
| Q9NR30 | S71 | Sugiyama | DDX21 | VFPKAKQVKKKAEPSEVDMNsPKSKKAKKKEEPSQNDIsPK |
| Q9NRA8 | S752 | Sugiyama | EIF4ENIF1 | KASEENLLSsssVPsADRDssPttNsKLSALQRSsCstPLS |
| Q9NTJ3 | S22 | Sugiyama | SMC4 CAPC SMC4L1 | PRKGTQPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsP |
| Q9NTJ3 | S27 | Sugiyama | SMC4 CAPC SMC4L1 | QPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsPAtAAE |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NUU7 | S85 | Sugiyama | DDX19A DDX19L | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYF8 | S285 | Sugiyama | BCLAF1 BTF KIAA0164 | IQHsPERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtI |
| Q9NYF8 | S287 | Sugiyama | BCLAF1 BTF KIAA0164 | HsPERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAP |
| Q9NYF8 | S290 | Sugiyama | BCLAF1 BTF KIAA0164 | ERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNA |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9UBK2 | S266 | ELM | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | SQSQHLQAKPTTLSLPLtPEsPNDPKGsPFENKTIERTLSV |
| Q9UBK2 | T263 | ELM | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | HTQSQSQHLQAKPTTLSLPLtPEsPNDPKGsPFENKTIERT |
| Q9UBK2 | T299 | ELM | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | TIERTLSVELSGTAGLTPPTtPPHKANQDNPFRAsPKLKSS |
| Q9UGV2 | S341 | Sugiyama | NDRG3 | MTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGtQESCEs |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UJU6 | S232 | Sugiyama | DBNL CMAP SH3P7 PP5423 | RELREAARREQRyQEQGGEAsPQRtWEQQQEVVSRNRNEQE |
| Q9UKV3 | T254 | Sugiyama | ACIN1 ACINUS KIAA0670 | ARAAKLsEGsQPAEEEEDQEtPsRNLRVRADRNLKTEEEEE |
| Q9UKX7 | S221 | Sugiyama | NUP50 NPAP60L PRO1146 | HGNsGRNsESEsNKVAAEtQsPsLFGstKLQQEStFLFHGN |
| Q9ULD2 | S1264 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | RsPtssAIPLQsPRNsGsFPsPsIsPR______________ |
| Q9ULD2 | S1268 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ssAIPLQsPRNsGsFPsPsIsPR__________________ |
| Q9UMR2 | S86 | Sugiyama | DDX19B DBP5 DDX19 TDBP | IRSNLVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQG |
| Q9UPQ0 | S212 | Sugiyama | LIMCH1 KIAA1102 | sPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsD |
| Q9UPQ0 | S217 | Sugiyama | LIMCH1 KIAA1102 | GRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEsDL |
| Q9UPQ0 | S670 | Sugiyama | LIMCH1 KIAA1102 | GNIELAssEPQHFtttVtRCsPtVAFVEFPssPQLKNDVSE |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S1404 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sELsPDAVEKAGMssNQsIssPVLDAVPRtPsRERsssAss |
| Q9UQ35 | S1552 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PLGQRsRsGssQELDVKPsAsPQERsEsDssPDSKAKTRTP |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9UQ35 | S387 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tPLLAERHGGsPQPLAttPLsQEPVNPPsEAsPtRDRsPPK |
| Q9UQ35 | S395 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | GGsPQPLAttPLsQEPVNPPsEAsPtRDRsPPKsPEKLPQs |
| Q9UQ35 | S857 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFEssP |
| Q9UQ35 | T384 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PAPtPLLAERHGGsPQPLAttPLsQEPVNPPsEAsPtRDRs |
| Q9UQ35 | T866 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sGtPPRQGsItsPQANEQsVtPQRRsCFEssPDPELKsRtP |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y3E2 | S81 | Sugiyama | BOLA1 CGI-143 | PPGSETHFRVAVVssRFEGLsPLQRHRLVHAALAEELGGPV |
| Q9Y3X0 | S376 | Sugiyama | CCDC9 | AAPRAYsDHDDRWETKEGAAsPAPEtPQPtsPEtsPKETPM |
| Q9Y3X0 | T381 | Sugiyama | CCDC9 | YsDHDDRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEI |
| Q9Y3X0 | T385 | Sugiyama | CCDC9 | DDRWETKEGAAsPAPEtPQPtsPEtsPKETPMQPPEIPAPA |
| Q9Y4E8 | S225 | Sugiyama | USP15 KIAA0529 | QGQVLVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPss |
| Q9Y4E8 | S229 | Sugiyama | USP15 KIAA0529 | LVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssLsNN |
| Q9Y4H2 | S1203 | Sugiyama | IRS2 | RKssEGGVGVGPGGGDEPPtsPRQLQPAPPLAPQGRPWtPG |
| Q9Y5Z4 | S181 | Sugiyama | HEBP2 C6orf34 SOUL | ILREDGKVFDEKVYYTAGYNsPVKLLNRNNEVWLIQKNEPT |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T513 | Sugiyama | DYNC1LI1 DNCLI1 | LDVHAELDRITRKPVtVsPttPtsPtEGEAs__________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
| Q9Y6G9 | T518 | Sugiyama | DYNC1LI1 DNCLI1 | ELDRITRKPVtVsPttPtsPtEGEAs_______________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 1.144880e-07 | 6.941 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.728762e-07 | 6.012 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.996222e-05 | 4.700 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.616629e-05 | 4.442 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.022904e-05 | 4.299 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.751478e-05 | 4.323 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.993630e-05 | 4.222 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.147826e-04 | 3.668 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.105156e-04 | 3.677 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.259443e-04 | 3.646 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.617023e-04 | 3.582 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.157828e-04 | 3.501 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.561814e-04 | 3.448 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.114033e-04 | 3.386 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.354958e-04 | 3.361 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.939147e-04 | 3.306 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.779274e-04 | 3.321 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.244285e-04 | 3.280 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.244285e-04 | 3.280 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.260064e-04 | 3.279 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.852242e-04 | 3.233 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.040872e-04 | 3.219 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.019243e-04 | 3.154 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.344732e-04 | 3.029 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.033136e-03 | 2.986 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.060963e-03 | 2.974 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.057366e-03 | 2.976 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.168973e-03 | 2.932 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.212056e-03 | 2.916 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.718027e-03 | 2.765 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.791565e-03 | 2.747 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.999853e-03 | 2.699 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.999853e-03 | 2.699 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.965401e-03 | 2.707 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.448429e-03 | 2.611 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.438185e-03 | 2.613 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.803893e-03 | 2.552 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.140969e-03 | 2.503 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.835418e-03 | 2.416 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.888854e-03 | 2.410 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.888854e-03 | 2.410 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.888854e-03 | 2.410 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.888854e-03 | 2.410 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.888854e-03 | 2.410 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.020806e-03 | 2.396 | 1 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.850113e-03 | 2.415 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.133288e-03 | 2.384 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.182818e-03 | 2.379 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.219643e-03 | 2.375 | 1 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.807144e-03 | 2.318 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.701354e-03 | 2.328 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.529463e-03 | 2.344 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.476053e-03 | 2.349 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.710131e-03 | 2.327 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.807144e-03 | 2.318 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.304329e-03 | 2.275 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.180785e-03 | 2.286 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.304329e-03 | 2.275 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.333676e-03 | 2.273 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.612749e-03 | 2.251 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.538733e-03 | 2.257 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.724748e-03 | 2.242 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.738387e-03 | 2.241 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.067471e-03 | 2.217 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.554054e-03 | 2.183 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.554054e-03 | 2.183 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.938325e-03 | 2.159 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.364960e-03 | 2.133 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.759413e-03 | 2.110 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.759413e-03 | 2.110 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.328883e-03 | 2.079 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.328883e-03 | 2.079 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.379633e-03 | 2.077 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.456357e-03 | 2.073 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.489972e-03 | 2.071 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.508731e-03 | 2.070 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.044628e-03 | 2.044 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 9.044628e-03 | 2.044 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.091183e-03 | 2.041 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.267900e-03 | 2.033 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.648864e-03 | 2.016 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.648864e-03 | 2.016 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.929664e-03 | 2.003 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.006266e-02 | 1.997 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.006266e-02 | 1.997 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.046341e-02 | 1.980 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.055707e-02 | 1.976 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.157024e-02 | 1.937 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.193749e-02 | 1.923 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.276713e-02 | 1.894 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.279769e-02 | 1.893 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.370347e-02 | 1.863 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.345220e-02 | 1.871 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.347225e-02 | 1.871 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.384275e-02 | 1.859 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.384275e-02 | 1.859 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.384275e-02 | 1.859 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.402366e-02 | 1.853 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.472127e-02 | 1.832 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.494978e-02 | 1.825 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.592561e-02 | 1.798 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.619620e-02 | 1.791 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.619620e-02 | 1.791 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.646263e-02 | 1.784 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.721793e-02 | 1.764 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.721793e-02 | 1.764 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.721793e-02 | 1.764 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.882119e-02 | 1.725 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.846116e-02 | 1.734 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.885912e-02 | 1.724 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.914409e-02 | 1.718 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.981363e-02 | 1.703 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.018730e-02 | 1.695 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.097523e-02 | 1.678 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.102703e-02 | 1.677 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.112288e-02 | 1.675 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.288921e-02 | 1.640 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.133951e-02 | 1.671 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.326516e-02 | 1.633 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.326516e-02 | 1.633 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.640321e-02 | 1.578 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.574373e-02 | 1.589 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.639675e-02 | 1.578 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.574373e-02 | 1.589 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.618109e-02 | 1.582 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.588192e-02 | 1.587 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.797806e-02 | 1.553 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.797806e-02 | 1.553 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.917603e-02 | 1.535 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.202632e-02 | 1.494 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.202632e-02 | 1.494 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.949718e-02 | 1.530 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.997073e-02 | 1.523 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.997073e-02 | 1.523 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.090288e-02 | 1.510 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.985099e-02 | 1.525 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.297553e-02 | 1.482 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.308619e-02 | 1.480 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.331303e-02 | 1.477 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.653839e-02 | 1.437 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.653839e-02 | 1.437 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.653839e-02 | 1.437 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.765407e-02 | 1.424 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.895161e-02 | 1.409 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.895161e-02 | 1.409 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.907172e-02 | 1.408 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.166499e-02 | 1.380 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.385713e-02 | 1.358 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.371584e-02 | 1.359 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.088627e-02 | 1.388 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.248886e-02 | 1.372 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.643961e-02 | 1.333 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.671974e-02 | 1.330 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.671974e-02 | 1.330 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.210351e-02 | 1.283 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.210351e-02 | 1.283 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.210351e-02 | 1.283 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.218086e-02 | 1.282 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.218086e-02 | 1.282 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.218086e-02 | 1.282 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.218086e-02 | 1.282 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.270958e-02 | 1.278 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.086522e-02 | 1.294 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.893807e-02 | 1.310 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.893807e-02 | 1.310 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.893807e-02 | 1.310 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.152593e-02 | 1.288 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.363320e-02 | 1.271 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.007688e-02 | 1.221 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.007688e-02 | 1.221 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.260654e-02 | 1.203 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.260654e-02 | 1.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.260654e-02 | 1.203 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.260654e-02 | 1.203 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.874180e-02 | 1.231 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.669990e-02 | 1.246 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.248362e-02 | 1.204 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.264687e-02 | 1.203 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.260654e-02 | 1.203 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.269621e-02 | 1.203 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.106571e-02 | 1.214 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.106571e-02 | 1.214 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.204278e-02 | 1.207 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.601134e-02 | 1.252 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.007688e-02 | 1.221 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.007688e-02 | 1.221 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.625262e-02 | 1.250 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.269621e-02 | 1.203 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.269621e-02 | 1.203 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.248362e-02 | 1.204 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.269621e-02 | 1.203 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.361087e-02 | 1.196 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.372438e-02 | 1.196 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.372438e-02 | 1.196 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.372438e-02 | 1.196 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 6.588039e-02 | 1.181 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 6.588039e-02 | 1.181 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 6.588039e-02 | 1.181 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 6.588039e-02 | 1.181 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.880183e-02 | 1.162 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.880183e-02 | 1.162 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.880183e-02 | 1.162 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.880183e-02 | 1.162 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.443883e-02 | 1.128 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.443883e-02 | 1.128 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.356115e-02 | 1.133 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.736137e-02 | 1.172 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.052928e-02 | 1.152 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.443883e-02 | 1.128 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.208899e-02 | 1.142 | 1 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.018988e-02 | 1.154 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.443883e-02 | 1.128 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.018988e-02 | 1.154 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.588039e-02 | 1.181 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.041493e-02 | 1.152 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.356115e-02 | 1.133 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.494972e-02 | 1.125 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.494972e-02 | 1.125 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.494972e-02 | 1.125 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.518430e-02 | 1.124 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.521479e-02 | 1.124 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.521479e-02 | 1.124 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.630695e-02 | 1.117 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.049514e-02 | 1.043 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.428218e-02 | 1.074 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.428218e-02 | 1.074 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.820771e-02 | 1.107 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.820771e-02 | 1.107 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.820771e-02 | 1.107 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.007022e-02 | 1.097 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.767124e-02 | 1.110 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.557499e-02 | 1.068 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.049514e-02 | 1.043 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 9.049514e-02 | 1.043 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.686525e-02 | 1.061 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.886105e-02 | 1.051 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.466444e-02 | 1.072 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.887148e-02 | 1.103 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.820771e-02 | 1.107 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.158210e-02 | 1.088 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.492455e-02 | 1.071 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.428218e-02 | 1.074 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.119204e-02 | 1.090 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.132040e-02 | 1.090 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 8.901956e-02 | 1.051 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.781199e-02 | 1.056 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.898044e-02 | 1.051 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.781199e-02 | 1.056 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.820771e-02 | 1.107 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.557499e-02 | 1.068 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.820771e-02 | 1.107 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.171237e-02 | 1.038 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.280470e-02 | 1.032 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.300458e-02 | 1.031 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.353826e-02 | 1.029 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.392177e-02 | 1.027 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.537360e-02 | 1.021 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.624968e-02 | 1.017 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.711907e-02 | 1.013 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.775343e-02 | 1.010 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.863831e-02 | 1.006 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.011482e-01 | 0.995 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.014307e-01 | 0.994 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.014307e-01 | 0.994 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 1.014307e-01 | 0.994 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.014307e-01 | 0.994 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.046546e-01 | 0.980 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.053552e-01 | 0.977 | 1 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.055507e-01 | 0.977 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.071978e-01 | 0.970 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.090660e-01 | 0.962 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 1.090660e-01 | 0.962 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.081836e-01 | 0.966 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.274171e-01 | 0.895 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.274171e-01 | 0.895 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.274171e-01 | 0.895 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.203724e-01 | 0.919 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.203724e-01 | 0.919 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.182901e-01 | 0.927 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.238075e-01 | 0.907 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.238075e-01 | 0.907 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.077625e-01 | 0.968 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.151881e-01 | 0.939 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.133463e-01 | 0.946 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.093923e-01 | 0.961 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.148781e-01 | 0.940 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.127304e-01 | 0.948 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 1.274171e-01 | 0.895 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.248156e-01 | 0.904 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.127304e-01 | 0.948 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.090660e-01 | 0.962 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.278203e-01 | 0.893 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.284433e-01 | 0.891 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.294883e-01 | 0.888 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.294883e-01 | 0.888 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.294883e-01 | 0.888 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.294883e-01 | 0.888 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.294883e-01 | 0.888 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.310443e-01 | 0.883 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.310443e-01 | 0.883 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.323152e-01 | 0.878 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.323152e-01 | 0.878 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.323757e-01 | 0.878 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.323757e-01 | 0.878 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.323757e-01 | 0.878 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.323757e-01 | 0.878 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.422160e-01 | 0.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.422160e-01 | 0.616 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.422160e-01 | 0.616 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.422160e-01 | 0.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.422160e-01 | 0.616 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.422160e-01 | 0.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.422160e-01 | 0.616 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.422160e-01 | 0.616 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.534799e-01 | 0.814 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 1.534799e-01 | 0.814 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.534799e-01 | 0.814 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.027493e-01 | 0.693 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.027493e-01 | 0.693 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.027493e-01 | 0.693 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.027493e-01 | 0.693 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.027493e-01 | 0.693 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.027493e-01 | 0.693 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.403515e-01 | 0.468 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.403515e-01 | 0.468 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.403515e-01 | 0.468 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.403515e-01 | 0.468 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.403515e-01 | 0.468 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.403515e-01 | 0.468 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.403515e-01 | 0.468 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.403515e-01 | 0.468 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.403515e-01 | 0.468 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.403515e-01 | 0.468 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.632511e-01 | 0.787 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.632511e-01 | 0.787 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.632511e-01 | 0.787 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.632511e-01 | 0.787 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.534573e-01 | 0.596 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.534573e-01 | 0.596 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.975064e-01 | 0.704 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.975064e-01 | 0.704 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.975064e-01 | 0.704 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.575217e-01 | 0.803 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.575217e-01 | 0.803 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.575217e-01 | 0.803 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.575217e-01 | 0.803 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.842636e-01 | 0.735 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.842636e-01 | 0.735 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.842636e-01 | 0.735 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.842636e-01 | 0.735 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.842636e-01 | 0.735 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.842636e-01 | 0.735 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.842636e-01 | 0.735 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.842636e-01 | 0.735 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.332822e-01 | 0.632 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.332822e-01 | 0.632 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.332822e-01 | 0.632 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.332822e-01 | 0.632 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.044059e-01 | 0.517 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.044059e-01 | 0.517 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.044059e-01 | 0.517 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.044059e-01 | 0.517 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.044059e-01 | 0.517 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.257831e-01 | 0.371 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.257831e-01 | 0.371 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.257831e-01 | 0.371 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.257831e-01 | 0.371 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.257831e-01 | 0.371 | 0 | 0 |
| Defective OPLAH causes OPLAHD | R-HSA-5578998 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.257831e-01 | 0.371 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.257831e-01 | 0.371 | 0 | 0 |
| Defective F8 sulfation at Y1699 | R-HSA-9674519 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.257831e-01 | 0.371 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.257831e-01 | 0.371 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.700683e-01 | 0.769 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.700683e-01 | 0.769 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.700683e-01 | 0.769 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.700683e-01 | 0.769 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.700683e-01 | 0.769 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.123488e-01 | 0.673 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.123488e-01 | 0.673 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.564723e-01 | 0.806 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.932219e-01 | 0.714 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.438676e-01 | 0.842 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.761054e-01 | 0.754 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.415210e-01 | 0.617 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.546828e-01 | 0.450 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.546828e-01 | 0.450 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.546828e-01 | 0.450 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.174003e-01 | 0.663 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.174003e-01 | 0.663 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.074539e-01 | 0.512 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.074539e-01 | 0.512 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.715262e-01 | 0.566 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.715262e-01 | 0.566 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.972249e-01 | 0.705 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.972249e-01 | 0.705 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.490018e-01 | 0.827 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.490018e-01 | 0.827 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.490018e-01 | 0.827 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.782495e-01 | 0.749 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.449887e-01 | 0.462 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.449887e-01 | 0.462 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.449887e-01 | 0.462 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.449887e-01 | 0.462 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.449887e-01 | 0.462 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.036080e-01 | 0.394 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.036080e-01 | 0.394 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.036080e-01 | 0.394 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.036080e-01 | 0.394 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.036080e-01 | 0.394 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.036080e-01 | 0.394 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.001548e-01 | 0.301 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.001548e-01 | 0.301 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.001548e-01 | 0.301 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.001548e-01 | 0.301 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.001548e-01 | 0.301 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.001548e-01 | 0.301 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.001548e-01 | 0.301 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.001548e-01 | 0.301 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.001548e-01 | 0.301 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.765796e-01 | 0.753 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.364994e-01 | 0.626 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.945363e-01 | 0.531 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.063341e-01 | 0.685 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.823298e-01 | 0.418 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.780497e-01 | 0.556 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.780497e-01 | 0.556 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.167803e-01 | 0.664 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.100472e-01 | 0.509 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.100472e-01 | 0.509 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.100472e-01 | 0.509 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.506885e-01 | 0.346 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.317923e-01 | 0.635 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.807702e-01 | 0.743 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.482506e-01 | 0.458 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.482506e-01 | 0.458 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.340783e-01 | 0.476 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.340783e-01 | 0.476 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.191690e-01 | 0.378 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.191690e-01 | 0.378 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.951512e-01 | 0.403 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.753524e-01 | 0.426 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.753524e-01 | 0.426 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.753524e-01 | 0.426 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.790188e-01 | 0.554 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.583141e-01 | 0.446 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.617044e-01 | 0.582 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.362907e-01 | 0.473 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.826539e-01 | 0.417 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.024365e-01 | 0.395 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.552462e-01 | 0.342 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.955817e-01 | 0.305 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.955817e-01 | 0.305 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.648976e-01 | 0.248 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.648976e-01 | 0.248 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.648976e-01 | 0.248 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.648976e-01 | 0.248 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.648976e-01 | 0.248 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.648976e-01 | 0.248 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.415567e-01 | 0.467 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.877145e-01 | 0.411 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.331302e-01 | 0.477 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.562533e-01 | 0.341 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.778117e-01 | 0.423 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.523118e-01 | 0.453 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.049121e-01 | 0.516 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.903463e-01 | 0.309 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.903463e-01 | 0.309 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.903463e-01 | 0.309 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.903463e-01 | 0.309 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.380646e-01 | 0.269 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.380646e-01 | 0.269 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.484040e-01 | 0.458 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.792001e-01 | 0.319 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.792001e-01 | 0.319 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.242961e-01 | 0.280 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.242961e-01 | 0.280 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.242961e-01 | 0.280 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.763464e-01 | 0.322 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.737480e-01 | 0.324 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.870420e-01 | 0.412 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.814898e-01 | 0.317 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.335930e-01 | 0.273 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.335930e-01 | 0.273 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.434496e-01 | 0.265 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.569605e-01 | 0.254 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.780083e-01 | 0.238 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.780083e-01 | 0.238 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.780083e-01 | 0.238 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.212579e-01 | 0.207 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.212579e-01 | 0.207 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.212579e-01 | 0.207 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.212579e-01 | 0.207 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.212579e-01 | 0.207 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.212579e-01 | 0.207 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.212579e-01 | 0.207 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.212579e-01 | 0.207 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.228421e-01 | 0.282 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.228421e-01 | 0.282 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.301535e-01 | 0.276 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.583169e-01 | 0.253 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.267630e-01 | 0.278 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.562272e-01 | 0.255 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.645318e-01 | 0.248 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.645318e-01 | 0.248 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.882384e-01 | 0.230 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.678892e-01 | 0.246 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.153580e-01 | 0.211 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.153580e-01 | 0.211 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.997934e-01 | 0.222 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.180589e-01 | 0.209 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.338166e-01 | 0.198 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.472845e-01 | 0.189 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.463774e-01 | 0.190 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.463774e-01 | 0.190 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.501154e-01 | 0.187 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.501154e-01 | 0.187 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.501154e-01 | 0.187 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.501154e-01 | 0.187 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.501154e-01 | 0.187 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.703205e-01 | 0.174 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.703205e-01 | 0.174 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.703205e-01 | 0.174 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.703205e-01 | 0.174 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.703205e-01 | 0.174 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.703205e-01 | 0.174 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.703205e-01 | 0.174 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.703205e-01 | 0.174 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.703205e-01 | 0.174 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.617044e-01 | 0.582 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.978038e-01 | 0.223 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.472845e-01 | 0.189 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.305572e-01 | 0.200 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.980586e-01 | 0.303 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.846236e-01 | 0.734 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.015109e-01 | 0.696 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.860378e-01 | 0.313 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.860378e-01 | 0.313 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.677910e-01 | 0.330 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.724624e-01 | 0.565 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.282603e-01 | 0.202 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.772047e-01 | 0.321 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.257217e-01 | 0.646 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.772047e-01 | 0.321 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.772047e-01 | 0.321 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.614757e-01 | 0.442 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.330629e-01 | 0.477 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.641412e-01 | 0.439 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.641412e-01 | 0.439 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.194768e-01 | 0.284 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.338122e-01 | 0.273 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.763464e-01 | 0.322 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.763464e-01 | 0.322 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.301737e-01 | 0.638 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.249980e-01 | 0.488 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.814899e-01 | 0.235 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.463774e-01 | 0.190 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.474310e-01 | 0.607 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.553567e-01 | 0.342 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.335930e-01 | 0.273 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.823693e-01 | 0.235 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.976027e-01 | 0.401 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.378675e-01 | 0.861 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.002522e-01 | 0.398 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.978038e-01 | 0.223 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.583141e-01 | 0.446 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.067413e-01 | 0.295 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.056980e-01 | 0.218 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.501154e-01 | 0.187 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.322627e-01 | 0.364 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.877145e-01 | 0.411 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.966766e-01 | 0.706 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.763464e-01 | 0.322 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.780497e-01 | 0.556 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.100472e-01 | 0.509 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.153378e-01 | 0.382 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.823502e-01 | 0.235 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.012781e-01 | 0.221 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.123488e-01 | 0.673 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.401873e-01 | 0.619 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.509369e-01 | 0.346 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.174003e-01 | 0.663 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.706984e-01 | 0.431 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.552523e-01 | 0.593 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.380646e-01 | 0.269 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.973681e-01 | 0.224 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.153580e-01 | 0.211 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.659038e-01 | 0.177 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.257372e-01 | 0.279 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.044059e-01 | 0.517 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.044059e-01 | 0.517 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.415210e-01 | 0.617 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.955817e-01 | 0.305 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 4.293786e-01 | 0.367 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 4.903463e-01 | 0.309 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.380646e-01 | 0.269 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.380646e-01 | 0.269 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.543947e-01 | 0.343 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.823890e-01 | 0.317 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.940126e-01 | 0.306 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.335930e-01 | 0.273 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.583169e-01 | 0.253 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.790848e-01 | 0.747 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.021183e-01 | 0.520 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.449887e-01 | 0.462 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.630197e-01 | 0.580 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.826539e-01 | 0.417 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.645385e-01 | 0.248 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.986098e-01 | 0.525 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.986098e-01 | 0.525 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.560642e-01 | 0.341 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.975064e-01 | 0.704 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.123488e-01 | 0.673 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.682135e-01 | 0.572 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.506885e-01 | 0.346 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.482506e-01 | 0.458 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.646253e-01 | 0.784 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.648976e-01 | 0.248 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.763464e-01 | 0.322 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.472951e-01 | 0.349 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.617761e-01 | 0.250 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.703205e-01 | 0.174 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.421220e-01 | 0.266 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.421220e-01 | 0.266 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 3.823298e-01 | 0.418 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.979529e-01 | 0.703 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.071033e-01 | 0.390 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.137509e-01 | 0.670 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.152310e-01 | 0.382 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.008485e-01 | 0.397 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.761054e-01 | 0.754 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.360959e-01 | 0.866 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.102495e-01 | 0.677 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.102495e-01 | 0.677 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.259098e-01 | 0.371 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.888796e-01 | 0.410 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.713510e-01 | 0.327 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.882384e-01 | 0.230 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.551027e-01 | 0.184 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.501154e-01 | 0.187 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.172003e-01 | 0.499 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.641412e-01 | 0.439 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.860378e-01 | 0.313 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.102495e-01 | 0.677 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.701038e-01 | 0.328 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.828945e-01 | 0.738 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.534573e-01 | 0.596 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.036080e-01 | 0.394 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.630197e-01 | 0.580 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.641412e-01 | 0.439 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.620652e-01 | 0.582 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.801701e-01 | 0.553 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.955817e-01 | 0.305 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.955817e-01 | 0.305 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.380646e-01 | 0.269 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.569605e-01 | 0.254 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.212579e-01 | 0.207 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.212579e-01 | 0.207 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.212579e-01 | 0.207 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.212579e-01 | 0.207 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.882384e-01 | 0.230 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.153580e-01 | 0.211 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.781457e-01 | 0.749 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.626496e-01 | 0.441 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.068894e-01 | 0.684 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.951512e-01 | 0.403 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.572257e-01 | 0.803 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.767943e-01 | 0.558 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.790848e-01 | 0.747 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.153265e-01 | 0.211 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.855149e-01 | 0.544 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.074539e-01 | 0.512 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.364994e-01 | 0.626 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.654365e-01 | 0.437 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.534573e-01 | 0.596 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.415210e-01 | 0.617 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.191690e-01 | 0.378 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.293786e-01 | 0.367 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.973681e-01 | 0.224 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.501232e-01 | 0.456 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.472845e-01 | 0.189 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.027493e-01 | 0.693 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.027493e-01 | 0.693 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.546828e-01 | 0.450 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.608230e-01 | 0.794 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.001548e-01 | 0.301 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.482506e-01 | 0.458 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.648976e-01 | 0.248 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.903463e-01 | 0.309 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.929926e-01 | 0.533 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 6.153580e-01 | 0.211 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.123242e-01 | 0.385 | 1 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.490018e-01 | 0.827 | 1 | 1 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.790188e-01 | 0.554 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.659000e-01 | 0.332 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.612355e-01 | 0.251 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.705264e-01 | 0.244 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.463871e-01 | 0.350 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.257372e-01 | 0.279 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.546828e-01 | 0.450 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.546828e-01 | 0.450 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.826539e-01 | 0.417 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.823890e-01 | 0.317 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.509751e-01 | 0.186 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.960767e-01 | 0.402 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.522602e-01 | 0.453 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.890209e-01 | 0.539 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.012781e-01 | 0.221 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.332822e-01 | 0.632 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.534468e-01 | 0.814 | 1 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.242961e-01 | 0.280 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.242961e-01 | 0.280 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.969780e-01 | 0.304 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.579993e-01 | 0.339 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.730867e-01 | 0.242 | 1 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.682135e-01 | 0.572 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.973681e-01 | 0.224 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.463774e-01 | 0.190 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.463774e-01 | 0.190 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.985130e-01 | 0.223 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 6.501154e-01 | 0.187 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.737480e-01 | 0.324 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.288805e-01 | 0.368 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.438676e-01 | 0.842 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.467225e-01 | 0.350 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.560642e-01 | 0.341 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.217217e-01 | 0.206 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.131588e-01 | 0.290 | 1 | 0 |
| G2/M Transition | R-HSA-69275 | 4.822573e-01 | 0.317 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.987548e-01 | 0.399 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.472323e-01 | 0.262 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.217217e-01 | 0.206 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.395814e-01 | 0.855 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.557867e-01 | 0.255 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.534799e-01 | 0.814 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.027493e-01 | 0.693 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.403515e-01 | 0.468 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.975064e-01 | 0.704 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.575217e-01 | 0.803 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.257831e-01 | 0.371 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.257831e-01 | 0.371 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.257831e-01 | 0.371 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.165391e-01 | 0.664 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.001548e-01 | 0.301 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.001548e-01 | 0.301 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.699325e-01 | 0.569 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.506885e-01 | 0.346 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.191690e-01 | 0.378 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.951512e-01 | 0.403 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.951512e-01 | 0.403 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.753524e-01 | 0.426 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.955817e-01 | 0.305 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.814723e-01 | 0.551 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.380646e-01 | 0.269 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.380646e-01 | 0.269 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.380646e-01 | 0.269 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.569605e-01 | 0.254 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.780083e-01 | 0.238 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.212579e-01 | 0.207 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.212579e-01 | 0.207 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.882384e-01 | 0.230 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.153580e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.463774e-01 | 0.190 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.501154e-01 | 0.187 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.501154e-01 | 0.187 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.501154e-01 | 0.187 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.703205e-01 | 0.174 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.703205e-01 | 0.174 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.537421e-01 | 0.596 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.579647e-01 | 0.446 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.741455e-01 | 0.759 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.180589e-01 | 0.209 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 4.871838e-01 | 0.312 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.871838e-01 | 0.312 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.748406e-01 | 0.240 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.748406e-01 | 0.240 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 1.932219e-01 | 0.714 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.552462e-01 | 0.342 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.270572e-01 | 0.644 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.708023e-01 | 0.567 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.293786e-01 | 0.367 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.936576e-01 | 0.226 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.180884e-01 | 0.661 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.846474e-01 | 0.233 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.790848e-01 | 0.747 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.630197e-01 | 0.580 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.648976e-01 | 0.248 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.860378e-01 | 0.313 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.380646e-01 | 0.269 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.612355e-01 | 0.251 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.134413e-01 | 0.212 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.439242e-01 | 0.353 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.786299e-01 | 0.748 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.583141e-01 | 0.446 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.242961e-01 | 0.280 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.102600e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.044059e-01 | 0.517 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.044059e-01 | 0.517 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.546828e-01 | 0.450 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.523107e-01 | 0.817 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.552462e-01 | 0.342 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.955817e-01 | 0.305 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.955817e-01 | 0.305 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.648976e-01 | 0.248 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.380646e-01 | 0.269 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.153580e-01 | 0.211 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.501154e-01 | 0.187 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.501154e-01 | 0.187 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.501154e-01 | 0.187 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.482506e-01 | 0.458 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.612355e-01 | 0.251 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.608230e-01 | 0.794 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.153378e-01 | 0.382 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.000144e-01 | 0.523 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.823693e-01 | 0.235 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.662179e-01 | 0.176 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.270572e-01 | 0.644 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.700827e-01 | 0.569 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.570292e-01 | 0.590 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.553567e-01 | 0.342 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.051027e-01 | 0.297 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.472845e-01 | 0.189 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.595587e-01 | 0.338 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.712020e-01 | 0.243 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.951512e-01 | 0.403 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.826539e-01 | 0.417 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.082596e-01 | 0.294 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.518759e-01 | 0.345 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.172003e-01 | 0.499 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.403515e-01 | 0.468 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.174003e-01 | 0.663 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.001548e-01 | 0.301 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.823298e-01 | 0.418 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.212647e-01 | 0.493 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.552462e-01 | 0.342 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.955817e-01 | 0.305 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.648976e-01 | 0.248 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.933894e-01 | 0.533 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.553567e-01 | 0.342 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.463774e-01 | 0.190 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.703205e-01 | 0.174 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.499914e-01 | 0.260 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.151385e-01 | 0.288 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.017056e-01 | 0.221 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.544819e-01 | 0.594 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.391875e-01 | 0.357 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.997934e-01 | 0.222 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.975064e-01 | 0.704 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.332822e-01 | 0.632 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.348692e-01 | 0.870 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.715262e-01 | 0.566 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 2.699325e-01 | 0.569 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.657400e-01 | 0.437 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.780083e-01 | 0.238 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.780083e-01 | 0.238 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.700683e-01 | 0.769 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.459553e-01 | 0.836 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.217738e-01 | 0.654 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.363878e-01 | 0.865 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.405509e-01 | 0.267 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.625875e-01 | 0.441 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.332822e-01 | 0.632 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 3.546828e-01 | 0.450 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 3.330629e-01 | 0.477 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.641412e-01 | 0.439 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.753524e-01 | 0.426 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.648976e-01 | 0.248 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.648976e-01 | 0.248 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.212579e-01 | 0.207 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.703205e-01 | 0.174 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.314048e-01 | 0.365 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.174003e-01 | 0.663 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.327183e-01 | 0.364 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.780083e-01 | 0.238 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.703205e-01 | 0.174 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.703205e-01 | 0.174 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.228489e-01 | 0.206 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.327183e-01 | 0.364 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.514641e-01 | 0.600 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.021183e-01 | 0.520 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.308888e-01 | 0.480 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.212579e-01 | 0.207 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.703205e-01 | 0.174 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.790188e-01 | 0.554 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.706467e-01 | 0.174 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.709587e-01 | 0.173 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.709587e-01 | 0.173 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.731720e-01 | 0.172 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.742921e-01 | 0.171 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.787893e-01 | 0.168 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.813766e-01 | 0.167 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.823253e-01 | 0.166 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.823253e-01 | 0.166 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.824683e-01 | 0.166 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.843469e-01 | 0.165 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.847386e-01 | 0.164 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.847386e-01 | 0.164 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.910512e-01 | 0.160 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.910512e-01 | 0.160 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.910512e-01 | 0.160 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.916522e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.924174e-01 | 0.160 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.984399e-01 | 0.156 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.984399e-01 | 0.156 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.984399e-01 | 0.156 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.985936e-01 | 0.156 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.088238e-01 | 0.149 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.095754e-01 | 0.149 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.102892e-01 | 0.149 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.102892e-01 | 0.149 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.120644e-01 | 0.147 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.120644e-01 | 0.147 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.120644e-01 | 0.147 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.120931e-01 | 0.147 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.130299e-01 | 0.147 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.130299e-01 | 0.147 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.130299e-01 | 0.147 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 7.130299e-01 | 0.147 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.130299e-01 | 0.147 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.130299e-01 | 0.147 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.130299e-01 | 0.147 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.130299e-01 | 0.147 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.130299e-01 | 0.147 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.130299e-01 | 0.147 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.130299e-01 | 0.147 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.130299e-01 | 0.147 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.130299e-01 | 0.147 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.130299e-01 | 0.147 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.140955e-01 | 0.146 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.140955e-01 | 0.146 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.148594e-01 | 0.146 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.171280e-01 | 0.144 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.217249e-01 | 0.142 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.221947e-01 | 0.141 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.221947e-01 | 0.141 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.221947e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.221947e-01 | 0.141 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.221947e-01 | 0.141 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.221947e-01 | 0.141 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.246369e-01 | 0.140 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.250949e-01 | 0.140 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.261881e-01 | 0.139 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.265206e-01 | 0.139 | 1 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.312578e-01 | 0.136 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.367727e-01 | 0.133 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.387447e-01 | 0.132 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.389100e-01 | 0.131 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.394322e-01 | 0.131 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.394322e-01 | 0.131 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.394322e-01 | 0.131 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.394322e-01 | 0.131 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.394322e-01 | 0.131 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.394322e-01 | 0.131 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.394322e-01 | 0.131 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.394322e-01 | 0.131 | 1 | 1 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.394322e-01 | 0.131 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.394322e-01 | 0.131 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.399141e-01 | 0.131 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.421335e-01 | 0.130 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.421335e-01 | 0.130 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.421335e-01 | 0.130 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.426652e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.426652e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.426652e-01 | 0.129 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.444633e-01 | 0.128 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.444633e-01 | 0.128 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.444633e-01 | 0.128 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.444633e-01 | 0.128 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.445854e-01 | 0.128 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.461886e-01 | 0.127 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.502085e-01 | 0.125 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.502085e-01 | 0.125 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.502085e-01 | 0.125 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.502085e-01 | 0.125 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.502085e-01 | 0.125 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.502085e-01 | 0.125 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.502085e-01 | 0.125 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.502085e-01 | 0.125 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.502085e-01 | 0.125 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.502085e-01 | 0.125 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.502085e-01 | 0.125 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.502085e-01 | 0.125 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.502085e-01 | 0.125 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.502085e-01 | 0.125 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.502085e-01 | 0.125 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.517449e-01 | 0.124 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.519268e-01 | 0.124 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.527871e-01 | 0.123 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.531808e-01 | 0.123 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.531808e-01 | 0.123 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.531808e-01 | 0.123 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.545864e-01 | 0.122 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.580763e-01 | 0.120 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.623234e-01 | 0.118 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.628574e-01 | 0.118 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.645098e-01 | 0.117 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.645439e-01 | 0.117 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.645439e-01 | 0.117 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.645439e-01 | 0.117 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.646401e-01 | 0.117 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.652832e-01 | 0.116 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.652832e-01 | 0.116 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.653374e-01 | 0.116 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.711183e-01 | 0.113 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.726150e-01 | 0.112 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.726150e-01 | 0.112 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.754127e-01 | 0.110 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.756161e-01 | 0.110 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.761133e-01 | 0.110 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.768852e-01 | 0.110 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.784334e-01 | 0.109 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.789602e-01 | 0.108 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.789602e-01 | 0.108 | 1 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.821253e-01 | 0.107 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.825724e-01 | 0.106 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.825724e-01 | 0.106 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.825724e-01 | 0.106 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.825724e-01 | 0.106 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.825724e-01 | 0.106 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.825724e-01 | 0.106 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.825724e-01 | 0.106 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.825724e-01 | 0.106 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.825724e-01 | 0.106 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.825724e-01 | 0.106 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.825724e-01 | 0.106 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.825724e-01 | 0.106 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.825724e-01 | 0.106 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.825724e-01 | 0.106 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.825724e-01 | 0.106 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.825724e-01 | 0.106 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.847006e-01 | 0.105 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.847006e-01 | 0.105 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.847006e-01 | 0.105 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.851853e-01 | 0.105 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.855741e-01 | 0.105 | 1 | 1 |
| Selective autophagy | R-HSA-9663891 | 7.858274e-01 | 0.105 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.861720e-01 | 0.104 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.868084e-01 | 0.104 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.875247e-01 | 0.104 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.875247e-01 | 0.104 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.875247e-01 | 0.104 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.875247e-01 | 0.104 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.880148e-01 | 0.103 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.896114e-01 | 0.103 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.912618e-01 | 0.102 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.961777e-01 | 0.099 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.999813e-01 | 0.097 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.027682e-01 | 0.095 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.027682e-01 | 0.095 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.027682e-01 | 0.095 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.027682e-01 | 0.095 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.027682e-01 | 0.095 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.038985e-01 | 0.095 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.038985e-01 | 0.095 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.078780e-01 | 0.093 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.085050e-01 | 0.092 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.085050e-01 | 0.092 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.085050e-01 | 0.092 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.085050e-01 | 0.092 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.107446e-01 | 0.091 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.107446e-01 | 0.091 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.107446e-01 | 0.091 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.107446e-01 | 0.091 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.107446e-01 | 0.091 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.107446e-01 | 0.091 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.107446e-01 | 0.091 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.107446e-01 | 0.091 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.107446e-01 | 0.091 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.107446e-01 | 0.091 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.131523e-01 | 0.090 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.188012e-01 | 0.087 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.188012e-01 | 0.087 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.188012e-01 | 0.087 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.195435e-01 | 0.086 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.195435e-01 | 0.086 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.195435e-01 | 0.086 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.195435e-01 | 0.086 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.212820e-01 | 0.086 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.253306e-01 | 0.083 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.276173e-01 | 0.082 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.276173e-01 | 0.082 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.276173e-01 | 0.082 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.276173e-01 | 0.082 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.276173e-01 | 0.082 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.276173e-01 | 0.082 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.276173e-01 | 0.082 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.350875e-01 | 0.078 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.350875e-01 | 0.078 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.350875e-01 | 0.078 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.350875e-01 | 0.078 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.350875e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.350875e-01 | 0.078 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.350875e-01 | 0.078 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.352680e-01 | 0.078 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.352680e-01 | 0.078 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.352680e-01 | 0.078 | 1 | 1 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.352680e-01 | 0.078 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.352680e-01 | 0.078 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.352680e-01 | 0.078 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.352680e-01 | 0.078 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.352680e-01 | 0.078 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.352680e-01 | 0.078 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.352680e-01 | 0.078 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.352680e-01 | 0.078 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.368681e-01 | 0.077 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.368681e-01 | 0.077 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.449935e-01 | 0.073 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.449935e-01 | 0.073 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.449935e-01 | 0.073 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.449935e-01 | 0.073 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.449935e-01 | 0.073 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.449935e-01 | 0.073 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.449935e-01 | 0.073 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.449935e-01 | 0.073 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.451794e-01 | 0.073 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.451794e-01 | 0.073 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.451794e-01 | 0.073 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.452413e-01 | 0.073 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.458057e-01 | 0.073 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.458057e-01 | 0.073 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.458057e-01 | 0.073 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.458194e-01 | 0.073 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.468601e-01 | 0.072 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.477831e-01 | 0.072 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.477831e-01 | 0.072 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.494631e-01 | 0.071 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.494631e-01 | 0.071 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.494631e-01 | 0.071 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.494631e-01 | 0.071 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.514485e-01 | 0.070 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.544506e-01 | 0.068 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.545109e-01 | 0.068 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.545109e-01 | 0.068 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.566150e-01 | 0.067 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.566150e-01 | 0.067 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.566150e-01 | 0.067 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.566150e-01 | 0.067 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.566150e-01 | 0.067 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.566150e-01 | 0.067 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.566150e-01 | 0.067 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.569526e-01 | 0.067 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.579834e-01 | 0.067 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.579834e-01 | 0.067 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.579834e-01 | 0.067 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.607623e-01 | 0.065 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.607623e-01 | 0.065 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.627343e-01 | 0.064 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.627343e-01 | 0.064 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.627343e-01 | 0.064 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.633853e-01 | 0.064 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.675024e-01 | 0.062 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.678239e-01 | 0.062 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.678239e-01 | 0.062 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.693310e-01 | 0.061 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.693310e-01 | 0.061 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.714440e-01 | 0.060 | 1 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.750487e-01 | 0.058 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.750487e-01 | 0.058 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.750487e-01 | 0.058 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.750487e-01 | 0.058 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.750487e-01 | 0.058 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.751967e-01 | 0.058 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.751967e-01 | 0.058 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.751967e-01 | 0.058 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.751967e-01 | 0.058 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.751967e-01 | 0.058 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.751967e-01 | 0.058 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.751967e-01 | 0.058 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.762030e-01 | 0.057 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.769912e-01 | 0.057 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.782505e-01 | 0.056 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.796187e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.796187e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.798889e-01 | 0.056 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.805027e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.819153e-01 | 0.055 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.836685e-01 | 0.054 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.856186e-01 | 0.053 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.862197e-01 | 0.052 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.862197e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.878311e-01 | 0.052 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.879717e-01 | 0.052 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.879717e-01 | 0.052 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.879717e-01 | 0.052 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.879717e-01 | 0.052 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.880882e-01 | 0.052 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.893130e-01 | 0.051 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.896978e-01 | 0.051 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.896978e-01 | 0.051 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.913713e-01 | 0.050 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.913713e-01 | 0.050 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.913713e-01 | 0.050 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.913713e-01 | 0.050 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.965597e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.971305e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.971305e-01 | 0.047 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.979926e-01 | 0.047 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.987981e-01 | 0.046 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.989555e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.996449e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.996449e-01 | 0.046 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.996449e-01 | 0.046 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.996449e-01 | 0.046 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.025606e-01 | 0.045 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.032029e-01 | 0.044 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.032029e-01 | 0.044 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.054505e-01 | 0.043 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.054505e-01 | 0.043 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.054505e-01 | 0.043 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.054505e-01 | 0.043 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.054505e-01 | 0.043 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.054505e-01 | 0.043 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.054505e-01 | 0.043 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.054505e-01 | 0.043 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.054505e-01 | 0.043 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.054505e-01 | 0.043 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.054505e-01 | 0.043 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.059266e-01 | 0.043 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.060461e-01 | 0.043 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.060461e-01 | 0.043 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.060461e-01 | 0.043 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.060461e-01 | 0.043 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.072297e-01 | 0.042 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.101751e-01 | 0.041 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.101751e-01 | 0.041 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.101751e-01 | 0.041 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.101751e-01 | 0.041 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.106994e-01 | 0.041 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.106994e-01 | 0.041 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.140333e-01 | 0.039 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.147376e-01 | 0.039 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.147376e-01 | 0.039 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.150317e-01 | 0.039 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.150317e-01 | 0.039 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.150317e-01 | 0.039 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.151346e-01 | 0.039 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.151689e-01 | 0.038 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.151689e-01 | 0.038 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.153652e-01 | 0.038 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.176816e-01 | 0.037 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.176816e-01 | 0.037 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.177056e-01 | 0.037 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.177056e-01 | 0.037 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.177056e-01 | 0.037 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.177056e-01 | 0.037 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.177056e-01 | 0.037 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.177056e-01 | 0.037 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.177056e-01 | 0.037 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.177056e-01 | 0.037 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.196623e-01 | 0.036 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.196623e-01 | 0.036 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.196623e-01 | 0.036 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.214272e-01 | 0.036 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.214577e-01 | 0.036 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.215191e-01 | 0.035 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.215191e-01 | 0.035 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.215191e-01 | 0.035 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.226904e-01 | 0.035 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.226904e-01 | 0.035 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.226904e-01 | 0.035 | 1 | 1 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.226904e-01 | 0.035 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.226904e-01 | 0.035 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.241775e-01 | 0.034 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.253830e-01 | 0.034 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.256490e-01 | 0.034 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.262038e-01 | 0.033 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.276520e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.281999e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.281999e-01 | 0.032 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.281999e-01 | 0.032 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.281999e-01 | 0.032 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.283729e-01 | 0.032 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.283729e-01 | 0.032 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.283729e-01 | 0.032 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.283729e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.283729e-01 | 0.032 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.283729e-01 | 0.032 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.283729e-01 | 0.032 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.283729e-01 | 0.032 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.283729e-01 | 0.032 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.283729e-01 | 0.032 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.283729e-01 | 0.032 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.288981e-01 | 0.032 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.288981e-01 | 0.032 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.299584e-01 | 0.032 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.300213e-01 | 0.032 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.302142e-01 | 0.031 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.309258e-01 | 0.031 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.344792e-01 | 0.029 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.350352e-01 | 0.029 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.358748e-01 | 0.029 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.358748e-01 | 0.029 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.358748e-01 | 0.029 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.365928e-01 | 0.028 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.365928e-01 | 0.028 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.365928e-01 | 0.028 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.365928e-01 | 0.028 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.376580e-01 | 0.028 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.376580e-01 | 0.028 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.376580e-01 | 0.028 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.376580e-01 | 0.028 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.376580e-01 | 0.028 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.376580e-01 | 0.028 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.376580e-01 | 0.028 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.376580e-01 | 0.028 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.381299e-01 | 0.028 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.387507e-01 | 0.027 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.388013e-01 | 0.027 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.406876e-01 | 0.027 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.410154e-01 | 0.026 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.410154e-01 | 0.026 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.410154e-01 | 0.026 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.426421e-01 | 0.026 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.427602e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.427670e-01 | 0.026 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.427670e-01 | 0.026 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.427670e-01 | 0.026 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.427670e-01 | 0.026 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.434851e-01 | 0.025 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.457399e-01 | 0.024 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.457399e-01 | 0.024 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.457399e-01 | 0.024 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.457399e-01 | 0.024 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.457399e-01 | 0.024 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.457399e-01 | 0.024 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.457399e-01 | 0.024 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.458302e-01 | 0.024 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.458881e-01 | 0.024 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.470083e-01 | 0.024 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.481519e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.489505e-01 | 0.023 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.489505e-01 | 0.023 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.489505e-01 | 0.023 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.502865e-01 | 0.022 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.506680e-01 | 0.022 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.506680e-01 | 0.022 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.511224e-01 | 0.022 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.527745e-01 | 0.021 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.527745e-01 | 0.021 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.527745e-01 | 0.021 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.527745e-01 | 0.021 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.527745e-01 | 0.021 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.527745e-01 | 0.021 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.531654e-01 | 0.021 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.544931e-01 | 0.020 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.544931e-01 | 0.020 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.544931e-01 | 0.020 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.546084e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.549372e-01 | 0.020 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.550570e-01 | 0.020 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.577227e-01 | 0.019 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.577227e-01 | 0.019 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.582139e-01 | 0.019 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.588975e-01 | 0.018 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.588975e-01 | 0.018 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.588975e-01 | 0.018 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.588975e-01 | 0.018 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.588975e-01 | 0.018 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.588975e-01 | 0.018 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.588975e-01 | 0.018 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.594836e-01 | 0.018 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.599352e-01 | 0.018 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.617925e-01 | 0.017 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.618615e-01 | 0.017 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.638991e-01 | 0.016 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.638991e-01 | 0.016 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.642269e-01 | 0.016 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.642269e-01 | 0.016 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.642269e-01 | 0.016 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.642269e-01 | 0.016 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.642269e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.642269e-01 | 0.016 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.649679e-01 | 0.015 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.656169e-01 | 0.015 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.661522e-01 | 0.015 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.661522e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.688655e-01 | 0.014 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.688655e-01 | 0.014 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.688655e-01 | 0.014 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.688655e-01 | 0.014 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.688655e-01 | 0.014 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.688655e-01 | 0.014 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.688655e-01 | 0.014 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.688655e-01 | 0.014 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.688655e-01 | 0.014 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.688655e-01 | 0.014 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.690214e-01 | 0.014 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.690214e-01 | 0.014 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.690214e-01 | 0.014 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.690214e-01 | 0.014 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.692436e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.692436e-01 | 0.014 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.697701e-01 | 0.013 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.697701e-01 | 0.013 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.697701e-01 | 0.013 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.711671e-01 | 0.013 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.714206e-01 | 0.013 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.714206e-01 | 0.013 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.716249e-01 | 0.013 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.720696e-01 | 0.012 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.729029e-01 | 0.012 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.729029e-01 | 0.012 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.729029e-01 | 0.012 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.732318e-01 | 0.012 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.733182e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.745899e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.745899e-01 | 0.011 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.745899e-01 | 0.011 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.748967e-01 | 0.011 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.755566e-01 | 0.011 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.764170e-01 | 0.010 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.764170e-01 | 0.010 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.764170e-01 | 0.010 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.764170e-01 | 0.010 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.764170e-01 | 0.010 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.771865e-01 | 0.010 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.771865e-01 | 0.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.774181e-01 | 0.010 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.774181e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.774181e-01 | 0.010 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.774212e-01 | 0.010 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.774212e-01 | 0.010 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.774275e-01 | 0.010 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.779023e-01 | 0.010 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.783209e-01 | 0.010 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.783209e-01 | 0.010 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.787447e-01 | 0.009 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.794755e-01 | 0.009 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.794755e-01 | 0.009 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.794755e-01 | 0.009 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.794755e-01 | 0.009 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.794755e-01 | 0.009 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.797027e-01 | 0.009 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.797027e-01 | 0.009 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.799404e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.806964e-01 | 0.008 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.817632e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.817632e-01 | 0.008 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.821375e-01 | 0.008 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.821375e-01 | 0.008 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.821375e-01 | 0.008 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.821375e-01 | 0.008 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.821375e-01 | 0.008 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.821884e-01 | 0.008 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.836228e-01 | 0.007 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.837613e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.840087e-01 | 0.007 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.841909e-01 | 0.007 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.841909e-01 | 0.007 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.844543e-01 | 0.007 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.844543e-01 | 0.007 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.844543e-01 | 0.007 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.844543e-01 | 0.007 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.844543e-01 | 0.007 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.844543e-01 | 0.007 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.845204e-01 | 0.007 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.845204e-01 | 0.007 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.846079e-01 | 0.007 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.846079e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.859737e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.859737e-01 | 0.006 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.859898e-01 | 0.006 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.859966e-01 | 0.006 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.864708e-01 | 0.006 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.864708e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.864708e-01 | 0.006 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.864708e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.864708e-01 | 0.006 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.864708e-01 | 0.006 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.868116e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.871824e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.871824e-01 | 0.006 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.872622e-01 | 0.006 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.875602e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.882259e-01 | 0.005 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.882259e-01 | 0.005 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.882259e-01 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.885569e-01 | 0.005 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.885569e-01 | 0.005 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.889593e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.889593e-01 | 0.005 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.889712e-01 | 0.005 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.889712e-01 | 0.005 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.889712e-01 | 0.005 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.893992e-01 | 0.005 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.894656e-01 | 0.005 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.897533e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.897533e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.897533e-01 | 0.004 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.897533e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.897533e-01 | 0.004 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.902256e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.902256e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.902256e-01 | 0.004 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.904298e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.910827e-01 | 0.004 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.910827e-01 | 0.004 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.910827e-01 | 0.004 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.910827e-01 | 0.004 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.913402e-01 | 0.004 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.913402e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.913402e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.913402e-01 | 0.004 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.914939e-01 | 0.004 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.917024e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.920773e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.921124e-01 | 0.003 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.921338e-01 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.921517e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.922396e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.922396e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.923853e-01 | 0.003 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.924012e-01 | 0.003 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.927749e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.928380e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.930025e-01 | 0.003 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.931481e-01 | 0.003 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.932092e-01 | 0.003 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.932092e-01 | 0.003 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.932209e-01 | 0.003 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.932209e-01 | 0.003 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.932466e-01 | 0.003 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.932466e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.932466e-01 | 0.003 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.933664e-01 | 0.003 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.933664e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.939892e-01 | 0.003 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.940617e-01 | 0.003 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.945200e-01 | 0.002 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.945933e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.946813e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.950113e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.951287e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.951287e-01 | 0.002 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.952949e-01 | 0.002 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.955492e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.955692e-01 | 0.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.958660e-01 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.961096e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.961124e-01 | 0.002 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.961124e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.961269e-01 | 0.002 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.961269e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.963211e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.965288e-01 | 0.002 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.966112e-01 | 0.001 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.966296e-01 | 0.001 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.966296e-01 | 0.001 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.966296e-01 | 0.001 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.966296e-01 | 0.001 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.966296e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.966296e-01 | 0.001 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.966296e-01 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.966375e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.966375e-01 | 0.001 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.967160e-01 | 0.001 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.967482e-01 | 0.001 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.967482e-01 | 0.001 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.969017e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.969054e-01 | 0.001 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.969054e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.970033e-01 | 0.001 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.970670e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.970670e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.970670e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.971264e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.973404e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.973473e-01 | 0.001 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.974477e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.974612e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.975491e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.976172e-01 | 0.001 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.977576e-01 | 0.001 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.977791e-01 | 0.001 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.977791e-01 | 0.001 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.977791e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.977791e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.977791e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.978437e-01 | 0.001 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.979284e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.980198e-01 | 0.001 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.980222e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.980397e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.980397e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.980674e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.980674e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.980674e-01 | 0.001 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.981217e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.981217e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.981408e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.982764e-01 | 0.001 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.983183e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.983183e-01 | 0.001 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.984100e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.984155e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.984574e-01 | 0.001 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.985366e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.985366e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.985366e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.985924e-01 | 0.001 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.986027e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.986133e-01 | 0.001 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.986137e-01 | 0.001 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.986558e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.986773e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.987119e-01 | 0.001 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.987266e-01 | 0.001 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.987266e-01 | 0.001 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.988052e-01 | 0.001 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.988920e-01 | 0.000 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.988920e-01 | 0.000 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.988920e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.989012e-01 | 0.000 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.989556e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.990581e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.991010e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.991300e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.991611e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.991611e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.992261e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.992261e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.992300e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.992366e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.992700e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.992733e-01 | 0.000 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.993648e-01 | 0.000 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.993648e-01 | 0.000 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.993648e-01 | 0.000 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.993648e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.993648e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.993648e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.994345e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.994409e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.994473e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.994521e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.994521e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.994562e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.994562e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.995026e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.995191e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.995191e-01 | 0.000 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.996359e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.996359e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997244e-01 | 0.000 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.997244e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.997384e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997626e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.997899e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997958e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997958e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997958e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.998105e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998136e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.998156e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.998421e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998421e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998626e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.998805e-01 | 0.000 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.998805e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.998837e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.998848e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.998910e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.998960e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.999028e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.999095e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999120e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999120e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999167e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.999213e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.999213e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.999290e-01 | 0.000 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.999404e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999434e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999549e-01 | 0.000 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.999551e-01 | 0.000 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.999564e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999616e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999658e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999698e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999703e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999742e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999768e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999822e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999830e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999830e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999845e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999848e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999871e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999872e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999916e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999931e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999939e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999944e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999945e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999957e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.999968e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.999979e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999980e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999982e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.999983e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999984e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999986e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999988e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.999988e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999990e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999990e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999991e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999991e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999999e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.002243e-09 | 8.698 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.584164e-08 | 7.253 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.191095e-08 | 7.087 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.889117e-08 | 7.103 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.270688e-07 | 6.896 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.393027e-07 | 6.856 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.915326e-07 | 6.718 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.820100e-07 | 6.317 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.565013e-07 | 6.121 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.013721e-06 | 5.994 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.003217e-06 | 5.999 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.863915e-07 | 6.052 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.014755e-06 | 5.994 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.124050e-06 | 5.949 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.301916e-06 | 5.885 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.346588e-06 | 5.871 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.744385e-06 | 5.758 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.773951e-06 | 5.751 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.342290e-06 | 5.630 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.342290e-06 | 5.630 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.586025e-06 | 5.445 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.106813e-06 | 5.386 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.367640e-06 | 5.270 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.293731e-06 | 5.201 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.293731e-06 | 5.201 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.274482e-05 | 4.895 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.355788e-05 | 4.868 | 1 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.449922e-05 | 4.839 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.600049e-05 | 4.796 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.826471e-05 | 4.738 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.028885e-05 | 4.693 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.204685e-05 | 4.657 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.248070e-05 | 4.648 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.286140e-05 | 4.641 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.446422e-05 | 4.611 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.581952e-05 | 4.588 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.726657e-05 | 4.564 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.844034e-05 | 4.546 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.850349e-05 | 4.545 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.205323e-05 | 4.494 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.629107e-05 | 4.440 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.517396e-05 | 4.454 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.684537e-05 | 4.434 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.638256e-05 | 4.334 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.935773e-05 | 4.307 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.065884e-05 | 4.295 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.442873e-05 | 4.264 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.900030e-05 | 4.229 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.810815e-05 | 4.236 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.900030e-05 | 4.229 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.952582e-05 | 4.158 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.396156e-05 | 4.027 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.127126e-04 | 3.948 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.127126e-04 | 3.948 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.238471e-04 | 3.907 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.204314e-04 | 3.919 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.286705e-04 | 3.891 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.421906e-04 | 3.847 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.498798e-04 | 3.824 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.582989e-04 | 3.801 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.825579e-04 | 3.739 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.862813e-04 | 3.730 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.862813e-04 | 3.730 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.947380e-04 | 3.711 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.234089e-04 | 3.651 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.237349e-04 | 3.650 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.431842e-04 | 3.614 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.638303e-04 | 3.579 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.638303e-04 | 3.579 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.767676e-04 | 3.558 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.970912e-04 | 3.527 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.403876e-04 | 3.468 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.524253e-04 | 3.453 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.725967e-04 | 3.429 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.760275e-04 | 3.425 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.760275e-04 | 3.425 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.760275e-04 | 3.425 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.628763e-04 | 3.335 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.967599e-04 | 3.304 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.129111e-04 | 3.290 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.526814e-04 | 3.258 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.076302e-04 | 3.216 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.882595e-04 | 3.230 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.529698e-04 | 3.185 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.679574e-04 | 3.115 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.115900e-04 | 3.091 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.667115e-04 | 3.015 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.031040e-03 | 2.987 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.031040e-03 | 2.987 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.629233e-04 | 3.016 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.042817e-03 | 2.982 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.082453e-03 | 2.966 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.120977e-03 | 2.950 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.141726e-03 | 2.942 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.210439e-03 | 2.917 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.196029e-03 | 2.922 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.271997e-03 | 2.896 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.440757e-03 | 2.841 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.504176e-03 | 2.823 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.408915e-03 | 2.851 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.466726e-03 | 2.834 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.408915e-03 | 2.851 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.408915e-03 | 2.851 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.408915e-03 | 2.851 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.427833e-03 | 2.845 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.507505e-03 | 2.822 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.529179e-03 | 2.816 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.611985e-03 | 2.793 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.629876e-03 | 2.788 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.697741e-03 | 2.770 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.739378e-03 | 2.760 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.817204e-03 | 2.741 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.930006e-03 | 2.714 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.935152e-03 | 2.713 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.775174e-03 | 2.751 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.124281e-03 | 2.673 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.247642e-03 | 2.648 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.247642e-03 | 2.648 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.258433e-03 | 2.646 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.272695e-03 | 2.643 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.330827e-03 | 2.632 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.372560e-03 | 2.625 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.372560e-03 | 2.625 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.831035e-03 | 2.548 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.831035e-03 | 2.548 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.880572e-03 | 2.541 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.912610e-03 | 2.536 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.300018e-03 | 2.481 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.831225e-03 | 2.417 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.868918e-03 | 2.412 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.868918e-03 | 2.412 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.868918e-03 | 2.412 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.970153e-03 | 2.401 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.970153e-03 | 2.401 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.267089e-03 | 2.370 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.600704e-03 | 2.337 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.712644e-03 | 2.327 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.979917e-03 | 2.303 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.321635e-03 | 2.274 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.028584e-03 | 2.299 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.392229e-03 | 2.268 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.451337e-03 | 2.263 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.506862e-03 | 2.259 | 1 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.619567e-03 | 2.250 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.789472e-03 | 2.237 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.811675e-03 | 2.236 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.811675e-03 | 2.236 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.263943e-03 | 2.203 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.465588e-03 | 2.189 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.525249e-03 | 2.185 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.525249e-03 | 2.185 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.525249e-03 | 2.185 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.822419e-03 | 2.166 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.964333e-03 | 2.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.110803e-03 | 2.148 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.223250e-03 | 2.085 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.220614e-03 | 2.141 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.114119e-03 | 2.091 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.226729e-03 | 2.085 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 8.385476e-03 | 2.076 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.526656e-03 | 2.069 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.863603e-03 | 2.052 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.863603e-03 | 2.052 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.322155e-03 | 2.030 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.347246e-03 | 2.029 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.354418e-03 | 2.029 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.494428e-03 | 2.023 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.494428e-03 | 2.023 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.555542e-03 | 2.020 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.020526e-02 | 1.991 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.023708e-02 | 1.990 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.034735e-02 | 1.985 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.062117e-02 | 1.974 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.125931e-02 | 1.948 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.133882e-02 | 1.945 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.248803e-02 | 1.904 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.246066e-02 | 1.904 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.263652e-02 | 1.898 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.214575e-02 | 1.916 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.154397e-02 | 1.938 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.154397e-02 | 1.938 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.150888e-02 | 1.939 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.284998e-02 | 1.891 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.263652e-02 | 1.898 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.341653e-02 | 1.872 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.276148e-02 | 1.894 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.373330e-02 | 1.862 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.411663e-02 | 1.850 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.507683e-02 | 1.822 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.516159e-02 | 1.819 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.636685e-02 | 1.786 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.638374e-02 | 1.786 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.774336e-02 | 1.751 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.774336e-02 | 1.751 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.804708e-02 | 1.744 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.805430e-02 | 1.743 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.815697e-02 | 1.741 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.815697e-02 | 1.741 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.841897e-02 | 1.735 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.916274e-02 | 1.718 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.947052e-02 | 1.711 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.274235e-02 | 1.643 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.329130e-02 | 1.633 | 1 | 1 |
| RAF activation | R-HSA-5673000 | 2.335597e-02 | 1.632 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.405137e-02 | 1.619 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.405137e-02 | 1.619 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.450983e-02 | 1.611 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.450983e-02 | 1.611 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.450983e-02 | 1.611 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.450983e-02 | 1.611 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.460437e-02 | 1.609 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.533827e-02 | 1.596 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.069683e-02 | 1.513 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.069683e-02 | 1.513 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.965800e-02 | 1.528 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.910837e-02 | 1.536 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.910837e-02 | 1.536 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.069683e-02 | 1.513 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.064410e-02 | 1.514 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.613710e-02 | 1.583 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.913591e-02 | 1.536 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.857957e-02 | 1.544 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.076746e-02 | 1.512 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.141518e-02 | 1.503 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.141518e-02 | 1.503 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.141518e-02 | 1.503 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.141518e-02 | 1.503 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.141518e-02 | 1.503 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.141518e-02 | 1.503 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.154372e-02 | 1.501 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.308658e-02 | 1.480 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.309556e-02 | 1.480 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.368070e-02 | 1.473 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.380478e-02 | 1.471 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.539851e-02 | 1.451 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.545870e-02 | 1.450 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.611252e-02 | 1.442 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.694065e-02 | 1.432 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.719315e-02 | 1.430 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.842571e-02 | 1.415 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.842571e-02 | 1.415 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.949860e-02 | 1.403 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.952534e-02 | 1.403 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.982233e-02 | 1.400 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.982233e-02 | 1.400 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.982233e-02 | 1.400 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.982233e-02 | 1.400 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.982233e-02 | 1.400 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.063130e-02 | 1.391 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.071597e-02 | 1.390 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.228403e-02 | 1.374 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.374784e-02 | 1.359 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.924749e-02 | 1.308 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.924749e-02 | 1.308 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.731229e-02 | 1.242 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.667920e-02 | 1.247 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.967808e-02 | 1.304 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.667920e-02 | 1.247 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.939966e-02 | 1.306 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.888531e-02 | 1.311 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.750470e-02 | 1.323 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.590247e-02 | 1.338 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.148076e-02 | 1.288 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.759577e-02 | 1.322 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.199049e-02 | 1.284 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.057077e-02 | 1.296 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.218582e-02 | 1.282 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.937244e-02 | 1.307 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.605476e-02 | 1.337 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.867469e-02 | 1.313 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.778196e-02 | 1.238 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.965484e-02 | 1.224 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.965484e-02 | 1.224 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.965484e-02 | 1.224 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.159699e-02 | 1.210 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.327546e-02 | 1.199 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.327546e-02 | 1.199 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 6.550916e-02 | 1.184 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.676752e-02 | 1.175 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.676752e-02 | 1.175 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.736083e-02 | 1.172 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.835359e-02 | 1.165 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.889349e-02 | 1.162 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.889349e-02 | 1.162 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.043881e-02 | 1.152 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.197135e-02 | 1.143 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.204706e-02 | 1.142 | 1 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.303224e-02 | 1.136 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.303224e-02 | 1.136 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.303224e-02 | 1.136 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.330543e-02 | 1.135 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.496606e-02 | 1.125 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.846891e-02 | 1.105 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.041193e-02 | 1.095 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.130381e-02 | 1.090 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 8.246713e-02 | 1.084 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.246713e-02 | 1.084 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 8.246713e-02 | 1.084 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 8.246713e-02 | 1.084 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 8.246713e-02 | 1.084 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.261472e-02 | 1.083 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.323265e-02 | 1.080 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.323265e-02 | 1.080 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.323265e-02 | 1.080 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 8.323265e-02 | 1.080 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.532687e-02 | 1.069 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.777231e-02 | 1.057 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.943021e-02 | 1.049 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.998077e-02 | 1.046 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.162910e-02 | 1.038 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.211064e-02 | 1.036 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.290963e-02 | 1.032 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.031651e-01 | 0.986 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.629653e-02 | 1.016 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 9.629653e-02 | 1.016 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.246783e-01 | 0.904 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.246783e-01 | 0.904 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.245752e-01 | 0.905 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.165883e-01 | 0.933 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.006042e-01 | 0.997 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.187673e-01 | 0.925 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.245752e-01 | 0.905 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.187673e-01 | 0.925 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.846073e-02 | 1.007 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.031651e-01 | 0.986 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.101324e-01 | 0.958 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.192076e-01 | 0.924 | 1 | 1 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.171761e-01 | 0.931 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.144607e-01 | 0.941 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.265902e-01 | 0.898 | 1 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.246278e-01 | 0.904 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.052273e-01 | 0.978 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.150228e-01 | 0.939 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.132985e-01 | 0.946 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.267305e-01 | 0.897 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.267305e-01 | 0.897 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.267305e-01 | 0.897 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.267305e-01 | 0.897 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.267305e-01 | 0.897 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.267305e-01 | 0.897 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.283884e-01 | 0.891 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.283884e-01 | 0.891 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.283884e-01 | 0.891 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.315919e-01 | 0.881 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.334881e-01 | 0.875 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.349085e-01 | 0.870 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.383519e-01 | 0.859 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.387770e-01 | 0.858 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.398711e-01 | 0.854 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.398711e-01 | 0.854 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.398711e-01 | 0.854 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.398711e-01 | 0.854 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.398711e-01 | 0.854 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.451315e-01 | 0.838 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.451315e-01 | 0.838 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.451315e-01 | 0.838 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.479929e-01 | 0.830 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.479929e-01 | 0.830 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.479929e-01 | 0.830 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.486301e-01 | 0.828 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.486301e-01 | 0.828 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.486301e-01 | 0.828 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.486434e-01 | 0.828 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.489174e-01 | 0.827 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 1.495124e-01 | 0.825 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.507415e-01 | 0.822 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.530599e-01 | 0.815 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.543011e-01 | 0.812 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.543011e-01 | 0.812 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.556467e-01 | 0.808 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.556467e-01 | 0.808 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.556467e-01 | 0.808 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.556467e-01 | 0.808 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.556467e-01 | 0.808 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.564962e-01 | 0.805 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.839446e-01 | 0.735 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.839446e-01 | 0.735 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.839446e-01 | 0.735 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.839446e-01 | 0.735 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.839446e-01 | 0.735 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.374133e-01 | 0.624 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.374133e-01 | 0.624 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.374133e-01 | 0.624 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.374133e-01 | 0.624 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.374133e-01 | 0.624 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.374133e-01 | 0.624 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.374133e-01 | 0.624 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.374133e-01 | 0.624 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.374133e-01 | 0.624 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.374133e-01 | 0.624 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.374133e-01 | 0.624 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.716515e-01 | 0.765 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.716515e-01 | 0.765 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.958690e-01 | 0.708 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.719415e-01 | 0.765 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.719415e-01 | 0.765 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.058379e-01 | 0.686 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.742397e-01 | 0.759 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.875750e-01 | 0.727 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.875750e-01 | 0.727 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.293451e-01 | 0.640 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.293451e-01 | 0.640 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.832594e-01 | 0.737 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.248448e-01 | 0.648 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.024386e-01 | 0.694 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.742397e-01 | 0.759 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.588927e-01 | 0.799 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.958690e-01 | 0.708 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.204707e-01 | 0.657 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.204707e-01 | 0.657 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.163876e-01 | 0.665 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.736268e-01 | 0.760 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.716515e-01 | 0.765 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.233177e-01 | 0.651 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.927767e-01 | 0.715 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.933599e-01 | 0.714 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 1.958690e-01 | 0.708 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.719415e-01 | 0.765 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.719415e-01 | 0.765 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.719415e-01 | 0.765 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.742397e-01 | 0.759 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 1.886925e-01 | 0.724 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.958690e-01 | 0.708 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.958690e-01 | 0.708 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.958690e-01 | 0.708 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.719415e-01 | 0.765 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.058379e-01 | 0.686 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.163876e-01 | 0.665 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.008508e-01 | 0.697 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.632180e-01 | 0.787 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.592478e-01 | 0.798 | 1 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.204707e-01 | 0.657 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 1.719415e-01 | 0.765 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.293451e-01 | 0.640 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.141109e-01 | 0.669 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.008508e-01 | 0.697 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.802856e-01 | 0.744 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.847752e-01 | 0.733 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.163876e-01 | 0.665 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.163876e-01 | 0.665 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.832594e-01 | 0.737 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.102746e-01 | 0.677 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 1.839446e-01 | 0.735 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.958690e-01 | 0.708 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.062168e-01 | 0.686 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.163876e-01 | 0.665 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.612483e-01 | 0.793 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.808379e-01 | 0.743 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.044681e-01 | 0.689 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.642540e-01 | 0.784 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.151576e-01 | 0.667 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.958690e-01 | 0.708 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.875750e-01 | 0.727 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.958690e-01 | 0.708 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.886925e-01 | 0.724 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.058379e-01 | 0.686 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.204707e-01 | 0.657 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.586309e-01 | 0.800 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.204707e-01 | 0.657 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.828521e-01 | 0.738 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.410739e-01 | 0.618 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.410739e-01 | 0.618 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.411692e-01 | 0.618 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.412040e-01 | 0.618 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.435421e-01 | 0.613 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.453026e-01 | 0.610 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.453026e-01 | 0.610 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.453026e-01 | 0.610 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.453026e-01 | 0.610 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.494870e-01 | 0.603 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.533338e-01 | 0.596 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.570388e-01 | 0.590 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.578502e-01 | 0.589 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.583634e-01 | 0.588 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.590507e-01 | 0.587 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.590507e-01 | 0.587 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.590507e-01 | 0.587 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.873817e-01 | 0.542 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.873817e-01 | 0.542 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.873817e-01 | 0.542 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.873817e-01 | 0.542 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.873817e-01 | 0.542 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.340787e-01 | 0.476 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.340787e-01 | 0.476 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.340787e-01 | 0.476 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.340787e-01 | 0.476 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.340787e-01 | 0.476 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.340787e-01 | 0.476 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.340787e-01 | 0.476 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.340787e-01 | 0.476 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.777184e-01 | 0.423 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.777184e-01 | 0.423 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.702291e-01 | 0.568 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.702291e-01 | 0.568 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.951314e-01 | 0.530 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.951314e-01 | 0.530 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.951314e-01 | 0.530 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.185007e-01 | 0.378 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.185007e-01 | 0.378 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.185007e-01 | 0.378 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.185007e-01 | 0.378 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.185007e-01 | 0.378 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.185007e-01 | 0.378 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.185007e-01 | 0.378 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.771949e-01 | 0.557 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.444619e-01 | 0.463 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.444619e-01 | 0.463 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.566125e-01 | 0.340 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.566125e-01 | 0.340 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.566125e-01 | 0.340 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.566125e-01 | 0.340 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.954557e-01 | 0.530 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.954557e-01 | 0.530 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.687224e-01 | 0.433 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.687224e-01 | 0.433 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.321387e-01 | 0.479 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.926207e-01 | 0.406 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.922286e-01 | 0.308 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.922286e-01 | 0.308 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.922286e-01 | 0.308 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.922286e-01 | 0.308 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.922286e-01 | 0.308 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.922286e-01 | 0.308 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.922286e-01 | 0.308 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.160999e-01 | 0.381 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.160999e-01 | 0.381 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.160999e-01 | 0.381 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.333276e-01 | 0.477 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.333276e-01 | 0.477 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.333276e-01 | 0.477 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.333276e-01 | 0.477 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.046860e-01 | 0.516 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.920388e-01 | 0.535 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.391125e-01 | 0.357 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.255123e-01 | 0.279 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.255123e-01 | 0.279 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.616189e-01 | 0.336 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.616189e-01 | 0.336 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.616189e-01 | 0.336 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.228805e-01 | 0.374 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.706402e-01 | 0.431 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.405869e-01 | 0.356 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.835865e-01 | 0.316 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.835865e-01 | 0.316 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.103615e-01 | 0.387 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.049893e-01 | 0.297 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.366566e-01 | 0.360 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.366566e-01 | 0.360 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.626798e-01 | 0.335 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.254768e-01 | 0.279 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.030656e-01 | 0.518 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.036174e-01 | 0.518 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.339676e-01 | 0.363 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.153205e-01 | 0.501 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.954557e-01 | 0.530 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.333276e-01 | 0.477 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.030656e-01 | 0.518 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.777184e-01 | 0.423 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.702291e-01 | 0.568 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.951314e-01 | 0.530 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.922286e-01 | 0.308 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.580793e-01 | 0.339 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.830395e-01 | 0.316 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.830395e-01 | 0.316 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.319580e-01 | 0.365 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.951314e-01 | 0.530 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.444619e-01 | 0.463 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.731359e-01 | 0.564 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.177774e-01 | 0.498 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.391125e-01 | 0.357 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.616189e-01 | 0.336 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.875958e-01 | 0.412 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.657965e-01 | 0.437 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.199056e-01 | 0.495 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.405869e-01 | 0.356 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.755593e-01 | 0.323 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.777184e-01 | 0.423 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.926207e-01 | 0.406 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.922286e-01 | 0.308 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.440883e-01 | 0.463 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.659842e-01 | 0.575 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.144079e-01 | 0.503 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.835865e-01 | 0.316 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.457702e-01 | 0.351 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.321387e-01 | 0.479 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.687224e-01 | 0.433 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.731359e-01 | 0.564 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.873817e-01 | 0.542 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.873817e-01 | 0.542 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.340787e-01 | 0.476 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.777184e-01 | 0.423 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.777184e-01 | 0.423 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.566125e-01 | 0.340 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.321387e-01 | 0.479 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.255123e-01 | 0.279 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.270706e-01 | 0.485 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.616189e-01 | 0.336 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.225430e-01 | 0.491 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.677170e-01 | 0.434 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.616189e-01 | 0.336 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.203748e-01 | 0.376 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.137854e-01 | 0.503 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.361959e-01 | 0.360 | 1 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.528623e-01 | 0.344 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.576419e-01 | 0.447 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.867813e-01 | 0.542 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.118543e-01 | 0.506 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.009994e-01 | 0.300 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.340787e-01 | 0.476 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.777184e-01 | 0.423 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.951314e-01 | 0.530 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.951314e-01 | 0.530 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.951314e-01 | 0.530 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.951314e-01 | 0.530 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.255123e-01 | 0.279 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.049893e-01 | 0.297 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.440883e-01 | 0.463 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.822209e-01 | 0.317 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.782305e-01 | 0.422 | 1 | 1 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.023762e-01 | 0.299 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.731359e-01 | 0.564 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.765232e-01 | 0.322 | 1 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.954557e-01 | 0.530 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.009994e-01 | 0.300 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.241428e-01 | 0.372 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.340787e-01 | 0.476 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 3.926207e-01 | 0.406 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.922286e-01 | 0.308 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.869325e-01 | 0.412 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.983437e-01 | 0.400 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.923312e-01 | 0.308 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.090509e-01 | 0.293 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.830395e-01 | 0.316 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.771949e-01 | 0.557 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.580793e-01 | 0.339 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.985078e-01 | 0.400 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.771949e-01 | 0.557 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.275426e-01 | 0.485 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.255123e-01 | 0.279 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.880459e-01 | 0.541 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.012340e-01 | 0.521 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.699120e-01 | 0.569 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.566125e-01 | 0.340 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.050740e-01 | 0.392 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.923312e-01 | 0.308 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.808299e-01 | 0.318 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.059078e-01 | 0.392 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.254768e-01 | 0.279 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.185007e-01 | 0.378 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.687224e-01 | 0.433 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.922286e-01 | 0.308 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.922286e-01 | 0.308 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.333276e-01 | 0.477 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.255123e-01 | 0.279 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.789007e-01 | 0.421 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.115854e-01 | 0.291 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.135399e-01 | 0.289 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.391125e-01 | 0.357 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.388772e-01 | 0.470 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.457539e-01 | 0.461 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.731359e-01 | 0.564 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.954557e-01 | 0.530 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.199056e-01 | 0.495 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.687224e-01 | 0.433 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.391125e-01 | 0.357 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.255123e-01 | 0.279 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.533974e-01 | 0.452 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.850342e-01 | 0.314 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.242296e-01 | 0.489 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.391125e-01 | 0.357 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.049893e-01 | 0.297 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.685191e-01 | 0.329 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.333276e-01 | 0.477 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.732680e-01 | 0.563 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.185007e-01 | 0.378 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.566125e-01 | 0.340 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.922286e-01 | 0.308 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.255123e-01 | 0.279 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.255123e-01 | 0.279 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.951314e-01 | 0.530 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.797418e-01 | 0.319 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.616189e-01 | 0.336 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.309037e-01 | 0.366 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.160999e-01 | 0.381 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.090509e-01 | 0.293 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.312830e-01 | 0.480 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.391125e-01 | 0.357 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.835865e-01 | 0.316 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.616189e-01 | 0.336 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.745166e-01 | 0.427 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.504735e-01 | 0.455 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.973993e-01 | 0.303 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.355909e-01 | 0.474 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.835865e-01 | 0.316 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.038270e-01 | 0.298 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.470950e-01 | 0.350 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 2.774496e-01 | 0.557 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.255857e-01 | 0.279 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.258070e-01 | 0.279 | 1 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.258070e-01 | 0.279 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.259483e-01 | 0.279 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.259483e-01 | 0.279 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.264499e-01 | 0.279 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.392587e-01 | 0.268 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.393891e-01 | 0.268 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.415944e-01 | 0.266 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.460244e-01 | 0.263 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.460607e-01 | 0.263 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.533634e-01 | 0.257 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.562623e-01 | 0.255 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.566161e-01 | 0.254 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.566161e-01 | 0.254 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.566161e-01 | 0.254 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.566161e-01 | 0.254 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.566161e-01 | 0.254 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.566161e-01 | 0.254 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.566161e-01 | 0.254 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.573909e-01 | 0.254 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.573909e-01 | 0.254 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.573909e-01 | 0.254 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.573909e-01 | 0.254 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.595624e-01 | 0.252 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.656308e-01 | 0.247 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.656308e-01 | 0.247 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.656308e-01 | 0.247 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.656308e-01 | 0.247 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.674034e-01 | 0.246 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.740989e-01 | 0.241 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.768632e-01 | 0.239 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.795221e-01 | 0.237 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.846192e-01 | 0.233 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.846192e-01 | 0.233 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.846192e-01 | 0.233 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.846192e-01 | 0.233 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.846192e-01 | 0.233 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.846192e-01 | 0.233 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.846192e-01 | 0.233 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.846192e-01 | 0.233 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.856827e-01 | 0.232 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.856827e-01 | 0.232 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.856827e-01 | 0.232 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.856827e-01 | 0.232 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.856827e-01 | 0.232 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.856827e-01 | 0.232 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.856827e-01 | 0.232 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.856827e-01 | 0.232 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.856827e-01 | 0.232 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.856827e-01 | 0.232 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.856827e-01 | 0.232 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 5.856827e-01 | 0.232 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.856827e-01 | 0.232 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.877222e-01 | 0.231 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.879796e-01 | 0.231 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.965992e-01 | 0.224 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.970262e-01 | 0.224 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.996260e-01 | 0.222 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.019335e-01 | 0.220 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.027551e-01 | 0.220 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.029866e-01 | 0.220 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.029866e-01 | 0.220 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.065877e-01 | 0.217 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.065877e-01 | 0.217 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.065877e-01 | 0.217 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.071513e-01 | 0.217 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.071513e-01 | 0.217 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.071513e-01 | 0.217 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.084645e-01 | 0.216 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.111146e-01 | 0.214 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.119281e-01 | 0.213 | 1 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.128455e-01 | 0.213 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.128455e-01 | 0.213 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.128455e-01 | 0.213 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.128455e-01 | 0.213 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.128455e-01 | 0.213 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.128455e-01 | 0.213 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.171762e-01 | 0.210 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.171762e-01 | 0.210 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.171762e-01 | 0.210 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.171762e-01 | 0.210 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.207327e-01 | 0.207 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.207327e-01 | 0.207 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.207327e-01 | 0.207 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 6.207327e-01 | 0.207 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.207327e-01 | 0.207 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.222702e-01 | 0.206 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.223150e-01 | 0.206 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.297721e-01 | 0.201 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.297721e-01 | 0.201 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.312163e-01 | 0.200 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.322127e-01 | 0.199 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.371770e-01 | 0.196 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.378600e-01 | 0.195 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.378600e-01 | 0.195 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.382290e-01 | 0.195 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 6.382290e-01 | 0.195 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.382290e-01 | 0.195 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 6.382290e-01 | 0.195 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.411738e-01 | 0.193 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.449384e-01 | 0.190 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.449384e-01 | 0.190 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.507526e-01 | 0.187 | 1 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.516907e-01 | 0.186 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.543734e-01 | 0.184 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.543734e-01 | 0.184 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.543734e-01 | 0.184 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.543734e-01 | 0.184 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.543734e-01 | 0.184 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.582741e-01 | 0.182 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.619497e-01 | 0.179 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.619497e-01 | 0.179 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.619497e-01 | 0.179 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.619497e-01 | 0.179 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.619497e-01 | 0.179 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.619497e-01 | 0.179 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.619497e-01 | 0.179 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.619497e-01 | 0.179 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.619497e-01 | 0.179 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.619497e-01 | 0.179 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.619497e-01 | 0.179 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.620096e-01 | 0.179 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.620096e-01 | 0.179 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.622352e-01 | 0.179 | 1 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.648323e-01 | 0.177 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.648323e-01 | 0.177 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.666184e-01 | 0.176 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.702797e-01 | 0.174 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.702797e-01 | 0.174 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.702797e-01 | 0.174 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.702797e-01 | 0.174 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.702797e-01 | 0.174 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.702797e-01 | 0.174 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.712446e-01 | 0.173 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.712446e-01 | 0.173 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.760019e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.760019e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.760019e-01 | 0.170 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.760019e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.760019e-01 | 0.170 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.783562e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.783562e-01 | 0.169 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.783562e-01 | 0.169 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.795510e-01 | 0.168 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.820449e-01 | 0.166 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.841164e-01 | 0.165 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.841164e-01 | 0.165 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 6.841164e-01 | 0.165 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.841164e-01 | 0.165 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.841164e-01 | 0.165 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.841164e-01 | 0.165 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.841164e-01 | 0.165 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.841164e-01 | 0.165 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.841164e-01 | 0.165 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.841164e-01 | 0.165 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.855875e-01 | 0.164 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.855875e-01 | 0.164 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.855875e-01 | 0.164 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.855875e-01 | 0.164 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.855875e-01 | 0.164 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.855875e-01 | 0.164 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.869103e-01 | 0.163 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.960909e-01 | 0.157 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.975566e-01 | 0.156 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.003069e-01 | 0.155 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.003069e-01 | 0.155 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.003069e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.016309e-01 | 0.154 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.016309e-01 | 0.154 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.032049e-01 | 0.153 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.048308e-01 | 0.152 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.048308e-01 | 0.152 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.048308e-01 | 0.152 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.048308e-01 | 0.152 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.048308e-01 | 0.152 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.048308e-01 | 0.152 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.048308e-01 | 0.152 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.048308e-01 | 0.152 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.079696e-01 | 0.150 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.111581e-01 | 0.148 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.142508e-01 | 0.146 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.180630e-01 | 0.144 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.241880e-01 | 0.140 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.241880e-01 | 0.140 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.241880e-01 | 0.140 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.241880e-01 | 0.140 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.241880e-01 | 0.140 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.241880e-01 | 0.140 | 1 | 1 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.241880e-01 | 0.140 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.241880e-01 | 0.140 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.241880e-01 | 0.140 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.241880e-01 | 0.140 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.279241e-01 | 0.138 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.280269e-01 | 0.138 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.280269e-01 | 0.138 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.285590e-01 | 0.138 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.309276e-01 | 0.136 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.337238e-01 | 0.134 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.388573e-01 | 0.131 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.405082e-01 | 0.130 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.410530e-01 | 0.130 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.410530e-01 | 0.130 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.410530e-01 | 0.130 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.415290e-01 | 0.130 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.422768e-01 | 0.129 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.422768e-01 | 0.129 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.422768e-01 | 0.129 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.422768e-01 | 0.129 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.422768e-01 | 0.129 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.422768e-01 | 0.129 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.422768e-01 | 0.129 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.422768e-01 | 0.129 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.422768e-01 | 0.129 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.422768e-01 | 0.129 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.422768e-01 | 0.129 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.462575e-01 | 0.127 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.535415e-01 | 0.123 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.591803e-01 | 0.120 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.591803e-01 | 0.120 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.591803e-01 | 0.120 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.655069e-01 | 0.116 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.655069e-01 | 0.116 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.655069e-01 | 0.116 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.655069e-01 | 0.116 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.718248e-01 | 0.112 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.718248e-01 | 0.112 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.718248e-01 | 0.112 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.718248e-01 | 0.112 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.733687e-01 | 0.112 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.749761e-01 | 0.111 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.749761e-01 | 0.111 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.749761e-01 | 0.111 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.749761e-01 | 0.111 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.749761e-01 | 0.111 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.749761e-01 | 0.111 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.749761e-01 | 0.111 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.749761e-01 | 0.111 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.749761e-01 | 0.111 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.760163e-01 | 0.110 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.762383e-01 | 0.110 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.762383e-01 | 0.110 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.769641e-01 | 0.110 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.769641e-01 | 0.110 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.812751e-01 | 0.107 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.812751e-01 | 0.107 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.812751e-01 | 0.107 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.812751e-01 | 0.107 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.817016e-01 | 0.107 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.817016e-01 | 0.107 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.879282e-01 | 0.104 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.879282e-01 | 0.104 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.894694e-01 | 0.103 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.897368e-01 | 0.103 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.897368e-01 | 0.103 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.897368e-01 | 0.103 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.897368e-01 | 0.103 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.897368e-01 | 0.103 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.897368e-01 | 0.103 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.905808e-01 | 0.102 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.965156e-01 | 0.099 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.965156e-01 | 0.099 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.984146e-01 | 0.098 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.984146e-01 | 0.098 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.984146e-01 | 0.098 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.992064e-01 | 0.097 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.999249e-01 | 0.097 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.029802e-01 | 0.095 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.035300e-01 | 0.095 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.035300e-01 | 0.095 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.035300e-01 | 0.095 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.035300e-01 | 0.095 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.035300e-01 | 0.095 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.035300e-01 | 0.095 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.035300e-01 | 0.095 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.035300e-01 | 0.095 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.035300e-01 | 0.095 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.035300e-01 | 0.095 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.035300e-01 | 0.095 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.052437e-01 | 0.094 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.063552e-01 | 0.093 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.077005e-01 | 0.093 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.158895e-01 | 0.088 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.164191e-01 | 0.088 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.164191e-01 | 0.088 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.164191e-01 | 0.088 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.164191e-01 | 0.088 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.164191e-01 | 0.088 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.164191e-01 | 0.088 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.164191e-01 | 0.088 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.180161e-01 | 0.087 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.180161e-01 | 0.087 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.214182e-01 | 0.085 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.214182e-01 | 0.085 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.237805e-01 | 0.084 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.259069e-01 | 0.083 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.271622e-01 | 0.082 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.271622e-01 | 0.082 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.271622e-01 | 0.082 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.271622e-01 | 0.082 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.271622e-01 | 0.082 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.271622e-01 | 0.082 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.271622e-01 | 0.082 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.272517e-01 | 0.082 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.272676e-01 | 0.082 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.280526e-01 | 0.082 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.284634e-01 | 0.082 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.284634e-01 | 0.082 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.284634e-01 | 0.082 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.284634e-01 | 0.082 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.284634e-01 | 0.082 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.284634e-01 | 0.082 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.284634e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.284634e-01 | 0.082 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.284634e-01 | 0.082 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.284634e-01 | 0.082 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.284634e-01 | 0.082 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.284634e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.320579e-01 | 0.080 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.320579e-01 | 0.080 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.329323e-01 | 0.079 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.329323e-01 | 0.079 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.330863e-01 | 0.079 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.330863e-01 | 0.079 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.330863e-01 | 0.079 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.333757e-01 | 0.079 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.358924e-01 | 0.078 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.358924e-01 | 0.078 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.358924e-01 | 0.078 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.358924e-01 | 0.078 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.397182e-01 | 0.076 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.397182e-01 | 0.076 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.397182e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.397182e-01 | 0.076 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.397182e-01 | 0.076 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.397182e-01 | 0.076 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.397182e-01 | 0.076 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.397182e-01 | 0.076 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.397182e-01 | 0.076 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.407335e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.442217e-01 | 0.074 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.442217e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.442217e-01 | 0.074 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.442217e-01 | 0.074 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.452406e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.461209e-01 | 0.073 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.502352e-01 | 0.070 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.502352e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.502352e-01 | 0.070 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.502352e-01 | 0.070 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.502352e-01 | 0.070 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.521653e-01 | 0.069 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.521653e-01 | 0.069 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.525115e-01 | 0.069 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.525115e-01 | 0.069 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.595279e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.597379e-01 | 0.066 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.597379e-01 | 0.066 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.597379e-01 | 0.066 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.600627e-01 | 0.065 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.600627e-01 | 0.065 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.600627e-01 | 0.065 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.636895e-01 | 0.064 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.652815e-01 | 0.063 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.691512e-01 | 0.061 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.692458e-01 | 0.061 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.692458e-01 | 0.061 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.692458e-01 | 0.061 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.692458e-01 | 0.061 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.692458e-01 | 0.061 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.692458e-01 | 0.061 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.692458e-01 | 0.061 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.692458e-01 | 0.061 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.738275e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.738275e-01 | 0.059 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.751094e-01 | 0.058 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.778269e-01 | 0.057 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.778269e-01 | 0.057 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.778269e-01 | 0.057 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.778269e-01 | 0.057 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 8.778269e-01 | 0.057 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.778269e-01 | 0.057 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.778269e-01 | 0.057 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.778269e-01 | 0.057 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.778269e-01 | 0.057 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.797697e-01 | 0.056 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.803725e-01 | 0.055 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.803725e-01 | 0.055 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.803725e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.803725e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.803725e-01 | 0.055 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.803725e-01 | 0.055 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.844194e-01 | 0.053 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.858452e-01 | 0.053 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.858452e-01 | 0.053 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.858452e-01 | 0.053 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.858452e-01 | 0.053 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.858452e-01 | 0.053 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.858452e-01 | 0.053 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.858452e-01 | 0.053 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.858452e-01 | 0.053 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.866025e-01 | 0.052 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.866025e-01 | 0.052 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.879296e-01 | 0.052 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.886465e-01 | 0.051 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.886465e-01 | 0.051 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.920217e-01 | 0.050 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.925306e-01 | 0.049 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 8.933378e-01 | 0.049 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.933378e-01 | 0.049 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.933378e-01 | 0.049 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.933378e-01 | 0.049 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.933378e-01 | 0.049 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.933378e-01 | 0.049 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.933378e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.933378e-01 | 0.049 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.933378e-01 | 0.049 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.979251e-01 | 0.047 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.979251e-01 | 0.047 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.981695e-01 | 0.047 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.981695e-01 | 0.047 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.003390e-01 | 0.046 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.003390e-01 | 0.046 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.003390e-01 | 0.046 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.003390e-01 | 0.046 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.003390e-01 | 0.046 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.003390e-01 | 0.046 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.013639e-01 | 0.045 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.024441e-01 | 0.045 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.035317e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.035317e-01 | 0.044 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.068811e-01 | 0.042 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.068811e-01 | 0.042 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.068811e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.068811e-01 | 0.042 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.068811e-01 | 0.042 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.068811e-01 | 0.042 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.068811e-01 | 0.042 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.071107e-01 | 0.042 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.071107e-01 | 0.042 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.083281e-01 | 0.042 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.086292e-01 | 0.042 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.094929e-01 | 0.041 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.129941e-01 | 0.040 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.129941e-01 | 0.040 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.129941e-01 | 0.040 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.134736e-01 | 0.039 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.134736e-01 | 0.039 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.134736e-01 | 0.039 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.180762e-01 | 0.037 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.187061e-01 | 0.037 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.187061e-01 | 0.037 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.187061e-01 | 0.037 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.194897e-01 | 0.036 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.224477e-01 | 0.035 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.224477e-01 | 0.035 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.226752e-01 | 0.035 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.240509e-01 | 0.034 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.265988e-01 | 0.033 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.272883e-01 | 0.033 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.290307e-01 | 0.032 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.290307e-01 | 0.032 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.290307e-01 | 0.032 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.295901e-01 | 0.032 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.305394e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.305394e-01 | 0.031 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.309814e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.336907e-01 | 0.030 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.336907e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.368390e-01 | 0.028 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.368390e-01 | 0.028 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.380450e-01 | 0.028 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.380450e-01 | 0.028 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.380450e-01 | 0.028 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.380450e-01 | 0.028 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.380450e-01 | 0.028 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.398544e-01 | 0.027 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.411943e-01 | 0.026 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.412450e-01 | 0.026 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.412800e-01 | 0.026 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.412900e-01 | 0.026 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.421137e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.421137e-01 | 0.026 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.421137e-01 | 0.026 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.421137e-01 | 0.026 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.421137e-01 | 0.026 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.421137e-01 | 0.026 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.459153e-01 | 0.024 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.459153e-01 | 0.024 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.459153e-01 | 0.024 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.463538e-01 | 0.024 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.472079e-01 | 0.024 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.474140e-01 | 0.023 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.494676e-01 | 0.023 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.494676e-01 | 0.023 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.506376e-01 | 0.022 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.518013e-01 | 0.021 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.527867e-01 | 0.021 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.527867e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.527867e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.527867e-01 | 0.021 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.530035e-01 | 0.021 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.530035e-01 | 0.021 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.530665e-01 | 0.021 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.539526e-01 | 0.020 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.548151e-01 | 0.020 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.555807e-01 | 0.020 | 1 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.558879e-01 | 0.020 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.580224e-01 | 0.019 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.587857e-01 | 0.018 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.587857e-01 | 0.018 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.587857e-01 | 0.018 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.598148e-01 | 0.018 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.603352e-01 | 0.018 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.614932e-01 | 0.017 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.614932e-01 | 0.017 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.614932e-01 | 0.017 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.614932e-01 | 0.017 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.617017e-01 | 0.017 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.640231e-01 | 0.016 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.640231e-01 | 0.016 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.640231e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.640231e-01 | 0.016 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.645993e-01 | 0.016 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.651057e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.663868e-01 | 0.015 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.663868e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.663868e-01 | 0.015 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.682265e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.682265e-01 | 0.014 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.682265e-01 | 0.014 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.684208e-01 | 0.014 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.684208e-01 | 0.014 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.686723e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.686723e-01 | 0.014 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.701795e-01 | 0.013 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.701795e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.702380e-01 | 0.013 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.706590e-01 | 0.013 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.706590e-01 | 0.013 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.706590e-01 | 0.013 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.710854e-01 | 0.013 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.725872e-01 | 0.012 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.725872e-01 | 0.012 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.725872e-01 | 0.012 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.725872e-01 | 0.012 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.725872e-01 | 0.012 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.725872e-01 | 0.012 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.727736e-01 | 0.012 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.731501e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.743887e-01 | 0.011 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.760719e-01 | 0.011 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.776446e-01 | 0.010 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.781830e-01 | 0.010 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.784084e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.789057e-01 | 0.009 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.791030e-01 | 0.009 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.791140e-01 | 0.009 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.791742e-01 | 0.009 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.800959e-01 | 0.009 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.800959e-01 | 0.009 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.804870e-01 | 0.009 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.804870e-01 | 0.009 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.812144e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.812209e-01 | 0.008 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.812209e-01 | 0.008 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.813537e-01 | 0.008 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.817697e-01 | 0.008 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.817697e-01 | 0.008 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.822841e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.831919e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.831919e-01 | 0.007 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.832887e-01 | 0.007 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.837656e-01 | 0.007 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.840880e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.861117e-01 | 0.006 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.878782e-01 | 0.005 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.884049e-01 | 0.005 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.886754e-01 | 0.005 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.889238e-01 | 0.005 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.901161e-01 | 0.004 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.901161e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.907260e-01 | 0.004 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.907662e-01 | 0.004 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.907662e-01 | 0.004 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.907662e-01 | 0.004 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.907662e-01 | 0.004 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.912605e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.913736e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.916303e-01 | 0.004 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.917648e-01 | 0.004 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.919411e-01 | 0.004 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.919411e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.922406e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.926896e-01 | 0.003 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.928547e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.933236e-01 | 0.003 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.938618e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.938755e-01 | 0.003 | 1 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.938892e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.942444e-01 | 0.003 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.942657e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.942657e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.945923e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.953250e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.954163e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.954738e-01 | 0.002 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.959202e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.961178e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.961888e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.964397e-01 | 0.002 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.966220e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.968581e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.969340e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.969573e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.970976e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.970976e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.972097e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.973729e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.979105e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.979355e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.981919e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.983172e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.984281e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.984840e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.984840e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.985342e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.986284e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.986590e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.987187e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.988032e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.988032e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.989290e-01 | 0.000 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.989997e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.990246e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.991489e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.992050e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.992161e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.992480e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.992574e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.992574e-01 | 0.000 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.992714e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.993064e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.994347e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.995009e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.995068e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.995697e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.995844e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.996725e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.996968e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.997143e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997508e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997911e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997911e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998043e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998455e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998658e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998703e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999032e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999446e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999666e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999720e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999725e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999786e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999838e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999854e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999880e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999960e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999978e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999988e-01 | 0.000 | 1 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.000000e+00 | 0.000 | 1 | 1 |